Publications

Format:  All Publications | By Year Content:   Publications | Patents

 

[441] The Light at the End of the Tunnel – Second Generation HPMA Conjugates for Cancer Treatment. J. Yang and J. Kopeček. Cur. Opin. Colloid Interface Sci. (2017). Submitted.
[440] A New Construct of Antibody-Drug Conjugates for Treatment of Non-Hodgkin’s Lymphoma. L. Zhang, Y. Fang, J. Kopeček, J. Yang. Eur. J. Pharm. Sci. 103 (2017): 36-46. [doi]
[439] Drug-Free Macromolecular Therapeutics: Impact of Structure on Induction of Apoptosis in Raji B Cells. L. Zhang, Y. Fang, J. Yang, J. Kopeček. J. Controlled Release (2017). [doi]
[438] Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts. J. Yang, R. Zhang, H. Pan, Y. Li, Y. Fang, L. Zhang, J. Kopeček. Mol. Pharmaceutics 14 (2017): 1384-1394. [doi]
[437] Healing Efficacy of Fracture-Targeted GSK3β Inhibitor-Loaded Micelles for Improved Fracture Repair. S.A. Low, C.V. Galliford, Y.L. Jones-Hall, J. Roy, J. Yang, P.S. Low, J. Kopeček. Nanomedicine (Lond.) 12 (2017): 185-193. [doi]
[436] Diverse Applications of Nanomedicine. B. Pelaz, C. Alexiou, R. Alvarez-Puebla, F. Alves, A. Andrews, S. Ashraf, L. Balogh, L. Ballerini, A. Bestetti, C. Brendel, S. Bossi, M. Carril, W. Chan, C. Chen, X. Chen, S. Shen, Z. Cheng, D. Cui, J. Du, C. Dullin, A. Escudero, N. Feliu, M. Gao, M. George, A. Grünweller, Z. Gu, Y. Gogotsi, N. Halas, N. Hampp, R. Hartmann, M. Hersam, P. Hunziker, J. Ji, X. Jiang, P. Jungebluth, P. Kadhiresan, K. Kataoka, A. Khademhosseini, J. Kopeček, N. Kotov, H. Krug, D.S. Lee, C.-M. Lehr, K.W. Leong, X.-J. Liang, M.L. Ling, L. Liz-Marzán, X. Ma, P. Macchiarini, H. Meng, H. Möhwald, P. Mulvaney, A. Nél, S. Nie, P. Nordlander, T. Okano, J. Oliviera, T.H. Park, R. Penner, M. Prato, V. Puntes, V. Rotello, A. Samarakoon, R. Schaak, Y. Shen, S. Sjoqvist, A.G. Skirtach, M. Sollman, M. Stevens, B.Z. Tang, R. Tietze, B. Udugama, H.-W. Sung, T. Weil, P. Weiss, I. Willner, Y. Wu, L. Yang, Z. Yue, Q. Zhang, Q. Zhang, X. Zhang, Y. Zhao, X. Zhou, W. Parak. ACS Nano 11 (2017): 2313-2381. [doi]
[435] FRET Imaging of Enzyme-Responsive HPMA Copolymer Conjugate. R. Zhang, J. Yang, D.C. Radford, Y. Fang, J. Kopeček. Macromol. Biosci. (2016). [doi]
[434] Indium-based and Iodine-based Labeling of HPMA Copolymer-Epirubicin Conjugates: Impact of Structure on the In Vivo Fate. L. Zhang, R. Zhang, J. Yang, J. Wang, J. Kopeček. J. Controlled Release. 235 (2016): 306-318. [doi]
[433] Tracking and quantifying polymer therapeutic distribution on a cellular level using 3D dSTORM. J.M. Hartley, R. Zhang, M. Gudheti, J. Yang, J. Kopeček. J. Controlled Release. 231 (2016): 50-59. [doi]
[432] Design of Smart Polymer-Based Nanomedicines. J Yang, J Kopeček. J. Controlled Release. (2015). [doi]
[431] N-(2-Hydroxypropyl)methacrylamide Copolymer–Drug Conjugates for Combination Chemotherapy of Acute Myeloid Leukemia. R Zhang, J Yang, Y Zhou, P J Shami, J Kopeček. Macromol Biosci. 16 (2016): 121-128. [doi]
[430] Smart Polymer-Based Nanomedicines. J M Hartley, J Kopeček. Smart Pharmaceutical Nanocarriers. Ed. V P Torchilin. (2016): 373-413.
[429] Hybrid Polymeric Hydrogels via Peptide Nucleic Acid (PNA)/DNA Complexation. T-W Chu, J Feng, J Yang, J Kopeček. J. Controlled Release. 220 (2015): 608-615. [doi]
[428] Biodistribution of Facture-Targeted GSK3β-loaded Micelles for Improved Fracture Healing. SA Low, CV Galiford, J Yang, PS Low, J. Kopeček. Biomacromolecules. 16 (2015): 3145-3153. [doi]
[427] FRET-Trackable Biodegradable HPMA Copolymer-Epirubicin Conjugates for Ovarian Carcinoma Therapy. J Yang, R Zhang DC Radford, J Kopeček. J. Controlled Release. 218 (2015): 36-44. [doi]
[426] Polymeric biomaterials and nanomedicines. J Yang, J Kopeček. J. Drug Deliv. Sci. Technol. 30 (2015): 318-330. [doi]
[425] Super-Resolution Imaging and Quantitative Analysis of Membrane Protein/Lipid Raft Clustering Mediated by Cell-Surface Self-Assembly of Hybrid Nanoconjugates. J M Hartley, T-W Chu, E M Peterson, R Zhang, J Yang, J Harris, J Kopeček. ChemBioChem. 16 (2015): 1725-1729. [doi]
[424] Enhancing Accumulation and Penetration of HPMA Copolymer–Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer. Z-H Peng, J Kopeček. J. Am. Chem. Soc.. 137 (2015): 6726-6729. [doi]
[423] Drug-free macromolecular therapeutics – a new paradigm in polymeric nanomedicines. T-W Chu, J Kopeček. Biomaterials Sci.. 3 (2015): 908-922. [doi]
[422] Multimodality Imaging of Coiled-Coil Mediated Self-Assembly in a “Drug-Free” Therapeutic System. R Zhang, J Yang, T-W Chu, J M Hartley, J Kopeček. Adv Healthc Mater. 4 (2015): 1054-1065. [doi]
[421] A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab. T-W Chu, R Zhang, J Yang, M P Chao, P J Shami, J Kopeček. Theranostics. 5 (2015): 834-846. [doi]
[420] Backbone Degradable and Coiled-Coil Based Macromolecular Therapeutics. J Yang, J Kopeček. Bioinspired Systems for Drug and Gene Delivery. Ed. Z-W Gu. (2015): 1-27.
[419] HPMA Copolymer CXCR4 Antagonist Conjugates Substantially Inhibited the Migration of Prostate Cancer Cells. Z-H Peng, J Kopeček. ACS Macro Lett. 3 (2014): 1240-1243. [doi]
[418] Combination therapy of prostate cancer with HPMA copolymer conjugates containing PI3K/mTOR inhibitor and docetaxel. Y Zhou, J Yang, R Zhang, J Kopeček. Eur J Pharm Biopharm. 89 (2014): 107-115. [doi]
[417] Drug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cells. T-W Chu, K M Kosak, P J Shami, J Kopeček. Drug Deliv Transl Res. 4 (2014): 389-394. [doi]
[416] Bone-Targeted Acid-Sensitive Doxorubicin Conjugate Micelles as Potential Osteosarcoma Therapeutics. S A Low, J Yang, J Kopeček. Bioconjugate Chem.. 25 (2014): 2012-2020. [doi]
[415] Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates. R Zhang, J Yang, M Sima, Y Zhou, J Kopeček. Proc. Natl. Acad. Sci. U.S.A.. 111 (2014): 12181-12186. [doi]
[414] Immunogenicity of coiled-coil based drug-free macromolecular therapeutics. Miloslav Kverka, J M Hartley, T-W Chu, J Yang, R Heidchen, J Kopeček. Biomaterials. 35 (2014): 5886-5896. [doi]
[413] Macromolecular therapeutics. J Yang, J Kopeček. J Control Release. 190 (2014): 288-303. [doi]
[412] Polymeric Drugs. J Yang, J Kopeček. Encyclopedia of Polymeric Nanomaterials. Springer Berlin Heidelberg (2014): 1-9.
[411] Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate. Z-H Peng, J Kopeček. Bioorg. Med. Chem. Lett.. 24 (2014): 1928-1933. [doi]
[410] Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis. T-W Chu, J Yang, R Zhang, M Sima, J Kopeček. ACS Nano. 8 (2014): 719-730. [doi]
[409] Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells. A Duangjai, K Luo, Y Zhou, J Yang, J Kopeček. Eur J Pharm Biopharm. 87 (2014): 187-196. [doi]
[408] HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects. Y Zhou, J Yang, J S Rhim, J Kopeček. J Control Release. 172 (2013): 946-953. [doi]
[407] Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer. Z-H Peng, M Sima, Mohamed E Salama, P Kopečková, J Kopeček. J Drug Target. 21 (2013): 968-980. [doi]
[406] Efficiency of high molecular weight backbone degradable HPMA copolymer-Prostaglandin E-1 conjugate in promotion of bone formation in ovariectomized rats. H Pan, M Sima, S C Miller, P Kopečková, J Yang, J Kopeček. Biomaterials. 34 (2013): 6528-6538. [doi]
[405] Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment. N Larson, J Yang, A Ray, D L Cheney, H Ghandehari, J Kopeček. Int J Pharm. 454 (2013): 435-443. [doi]
[404] Cancer Stem Cells: Potential Target For Anti-Cancer Nanomedicines. Y Zhou, J Yang, J Kopeček. Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications. Eds. C Scholz, J Kressler. (2013): 127-149.
[403] Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel. R Zhang, K Luo, J Yang, M Sima, Y Sun, M M Janát-Amsbury, J Kopeček. J Control Release. 166 (2013): 66-74. [doi]
[402] Synthesis of Long-Circulating, Backbone Degradable HPMA CopolymerDoxorubicin Conjugates and Evaluation of Molecular-Weight-Dependent Antitumor Efficacy. H Pan, M Sima, J Yang, J Kopeček. Macromol Biosci. 13 (2013): 155-160. [doi]
[401] Polymer–drug conjugates: Origins, progress to date and future directions. J Kopeček. Adv. Drug. Deliv. Rev.. 65 (2013): 49-59. [doi]
[400] Biological rationale for the design of polymeric anti-cancer nanomedicines. Y Zhou, J Kopeček. J Drug Target. 21 (2013): 1-26. [doi]
[399] Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis. T-W Chu, J Yang, J Kopeček. Biomaterials. 33 (2012): 7174-7181. [doi]
[398] Smart Self-Assembled Hybrid Hydrogel Biomaterials. J Kopeček, J Yang. Angewandte Chemie International Edition. 51 (2012): 7396-7417. [doi]
[397] Hyaluronan Oligomers-HPMA Copolymer Conjugates for Targeting Paclitaxel to CD44-Overexpressing Ovarian Carcinoma. G Journo-Gershfeld, D Kapp, Y Shamay, J Kopeček, A David. Pharm. Res.. 29 (2012): 1121-1133. [doi]
[396] Biological Activity of Anti-CD20 Multivalent HPMA Copolymer-Fab’ Conjugates. R N Johnson, P Kopečková, J Kopeček. Biomacromolecules. 13 (2012): 727-735. [doi]
[395] Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells. Y Zhou, J Yang, J Kopeček. Biomaterials. 33 (2012): 1863-1872. [doi]
[394] Targeting polymer therapeutics to bone. S A Low, J Kopeček. Adv. Drug. Deliv. Rev.. 64 (2012): 1189-1204. [doi]
[393] Targeting of Multidrug-Resistant Human Ovarian Carcinoma Cells With Anti-P-Glycoprotein Antibody Conjugates. K D Fowers, J Kopeček. Macromol Biosci. 12 (2012): 502-514. [doi]
[392] Prostate-Cancer-Targeted N-(2-Hydroxypropyl)methacrylamide Copolymer/Docetaxel Conjugates. J Liu, P Kopečková, H Pan, M Sima, P Buehler, P Wolf, U Elsaesser-Beile, J Kopeček. Macromol Biosci. 12 (2012): 412-422. [doi]
[391] Coiled-coil based drug-free macromolecular therapeutics: In vivo efficacy. K Wu, J Yang, J Liu, J Kopeček. J Control Release. 157 (2012): 126-131. [doi]
[390] Design of Polymer-Drug Conjugates. J Kopeček, P Kopečková. Drug Delivery in Oncology. Eds. F Kratz, P D Senter, H Steinhagen. Drug Delivery in Oncology: From Basic Research to Cancer Therapy, Vols 1-3 (2012): 485-512.
[389] Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances. E Segal, H Pan, L Benayoun, P Kopečková, Y Shaked, J Kopeček, R Satchi-Fainaro. Biomaterials. 32 (2011): 4450-4463. [doi]
[388] Synthesis and Characterization of Poly(ε-caprolactone)-block-poly[N-(2-hydroxypropyl)methacrylamide] Micelles for Drug Delivery. S G Krimmer, H Pan, J Liu, J Yang, J Kopeček. Macromol Biosci. 11 (2011): 1041-1051. [doi]
[387] Biodegradable Multiblock Poly[N-(2-hydroxypropyl)methacrylamide] via Reversible Addition\textbackslashtextminusFragmentation Chain Transfer Polymerization and Click Chemistry. K Luo, J Yang, P Kopečková, J Kopeček. Macromolecules. 44 (2011): 2481-2488. [doi]
[386] Backbone Degradable Multiblock N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates via Reversible Addition\textbackslashtextminusFragmentation Chain Transfer Polymerization and Thiol\textbackslashtextminusene Coupling Reaction. H Pan, J Yang, P Kopečková, J Kopeček. Biomacromolecules. 12 (2011): 247-252. [doi]
[385] Synthesis of biodegradable multiblock copolymers by click coupling of RAFT-generated heterotelechelic polyHPMA conjugates. J Yang, K Luo, H Pan, P Kopečková, J Kopeček. React Funct Polym. 71 (2011): 294-302. [doi]
[384] Study of the therapeutic benefit of cationic copolymer administration to vascular endothelium under mechanical stress. K Giantsos-Adams, V Lopez-Quintero, P Kopečková, J Kopeček, John M Tarbell, R Dull. Biomaterials. 32 (2011): 288-294. [doi]
[383] Hybrid hydrogels self-assembled from graft copolymers containing complementary β-sheets as hydroxyapatite nucleation scaffolds. L C Wu, J Yang, J Kopeček. Biomaterials. 32 (2011): 5341-5353. [doi]
[382] Biomaterials and Drug Delivery: Past, Present, and Future. J Kopeček. Mol. Pharm. 7 (2010): 922-925. [doi]
[381] Endocytic uptake of a large array of HPMA copolymers: Elucidation into the dependence on the physicochemical characteristics. J Liu, H Bauer, J Callahan, P Kopečková, H Pan, J Kopeček. J Control Release. 143 (2010): 71-79. [doi]
[380] HPMA copolymers: Origins, early developments, present, and future. J Kopeček, P Kopečková. Adv. Drug. Deliv. Rev.. 62 (2010): 122-149. [doi]
[379] Drug-Free Macromolecular Therapeutics: Induction of Apoptosis by Coiled-Coil-Mediated Cross-Linking of Antigens on the Cell Surface. K Wu, J Liu, R N Johnson, J Yang, J Kopeček. Angew. Chem. Int. Ed.. 122 (2010): 1493-1497. [doi]
[378] Synthesis and Characterization of Enzymatically Degradable PEG-Based Peptide-Containing Hydrogels. J Yang, M T Jacobsen, H Pan, J Kopeček. Macromol Biosci. 10 (2010): 445-454. [doi]
[377] Hydrogels: From soft contact lenses and implants to self-assembled nanomaterials. J Kopeček. J Polym Sci A Polym Chem. 47 (2009): 5929-5946. [doi]
[376] Self-Assembled Hydrogels from Poly[N-(2-hydroxypropyl)methacrylamide] Grafted with β-Sheet Peptides. L C Radu-Wu, J Yang, K Wu, J Kopeček. Biomacromolecules. 10 (2009): 2319-2327. [doi]
[375] Stimuli-Responsive Properties of Peptide-Based Copolymers Studied via Directional Growth of Self-Assembled Patterns on Solid Substrate. R Sheparovych, Y Roiter, J Yang, J Kopeček, S Minko. Biomacromolecules. 10 (2009): 1955-1961. [doi]
[374] Biorecognition and Subcellular Trafficking of HPMA Copolymer-Anti-PSMA Antibody Conjugates by Prostate Cancer Cells. J Liu, P Kopečková, P Buehler, P Wolf, H Pan, H Bauer, U Elsaesser-Beile, J Kopeček. Mol. Pharm. 6 (2009): 959-970. [doi]
[373] Intracellular Trafficking and Subcellular Distribution of a Large Array of HPMA Copolymers. J Callahan, P Kopečková, J Kopeček. Biomacromolecules. 10 (2009): 1704-1714. [doi]
[372] Antitumor efficacy of colon-specific HPMA copolymer/9-aminocamptothecin conjugates in mice bearing human-colon carcinoma xenografts. S-Q Gao, Y Sun, P Kopečková, C M Peterson, J Kopeček. Macromol Biosci. 9 (2009): 1135-1142. [doi]
[371] Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics. E Segal, H Pan, P Ofek, T Udagawa, P Kopečková, J Kopeček, R Satchi-Fainaro. PLoS ONE. 4 (2009): e5233. [doi]
[370] Synthesis and Evaluation of Multivalent Branched HPMA Copolymer\textbackslashtextminusFab´ Conjugates Targeted to the B-Cell Antigen CD20. R N Johnson, P Kopečková, J Kopeček. Bioconjugate Chem.. 20 (2009): 129-137. [doi]
[369] Peptide-directed self-assembly of hydrogels. J Kopeček, J Yang. Acta Biomater. 5 (2009): 805-816. [doi]
[368] Self-Assembling Diblock Copolymers of Poly[N-(2-hydroxypropyl)methacrylamide] and a β-Sheet Peptide. L C Radu, J Yang, J Kopeček. Macromol Biosci. 9 (2009): 36-44. [doi]
[367] Coiled-Coil Hydrogels: Effect of Grafted Copolymer Composition and Cyclization on Gelation. K Dušek, M Dušková-Smrčková, J Yang, J Kopeček. Macromolecules. 42 (2009): 2265-2274. [doi]
[366] Feasibility of Using a Bone-Targeted, Macromolecular Delivery System Coupled with Prostaglandin E1 to Promote Bone Formation in Aged, Estrogen-Deficient Rats. S C Miller, H Pan, D Wang, B M Bowman, P Kopečková, J Kopeček. Pharm. Res.. 25 (2008): 2889-2895. [doi]
[365] Smart hydrogels containing adenylate kinase: translating substrate recognition into macroscopic motion. W Yuan, J Yang, P Kopečková, J Kopeček. J. Am. Chem. Soc.. 130 (2008): 15760-15761. [doi]
[364] Combination Chemotherapy and Photodynamic Therapy with Fab´ Fragment Targeted HPMA Copolymer Conjugates in Human Ovarian Carcinoma Cells. J Hongrapipat, P Kopečková, J Liu, S Prakongpan, J Kopeček. Mol. Pharm. 5 (2008): 696-709. [doi]
[363] Novel HPMA Copolymer-Bound Constructs for Combined Tumor and Mitochondrial Targeting. V Cuchelkar, P Kopečková, J Kopeček. Mol. Pharm. 5 (2008): 776-786. [doi]
[362] Biodistribution and Pharmacokinetic Studies of Bone-Targeting N-(2-Hydroxypropyl)methacrylamide Copolymer\textbackslashtextminusAlendronate Conjugates. H Pan, M Sima, P Kopečková, K Wu, S Gao, J Liu, D Wang, S C Miller, J Kopeček. Mol. Pharm. 5 (2008): 548-558. [doi]
[361] Release of Prostaglandin E1 from N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates by Bone Cells. H Pan, J Liu, Y Dong, M Sima, P Kopečková, M L Brandi, J Kopeček. Macromol Biosci. 8 (2008): 599-605. [doi]
[360] Synthesis and Biological Evaluation of Disulfide-Linked HPMA Copolymer-Mesochlorin e6 Conjugates. V Cuchelkar, P Kopečková, J Kopeček. Macromol Biosci. 8 (2008): 375-383. [doi]
[359] Novel Synthesis of HPMA Copolymers Containing Peptide Grafts and Their Self-Assembly Into Hybrid Hydrogels. K Wu, J Yang, Č Koňák, P Kopečková, J Kopeček. Macromol Chem Phys. 209 (2008): 467-475. [doi]
[358] Dynamic Light Scattering Study of Self-Assembly of HPMA Hybrid Graft Copolymers. J Yang, K Wu, Č Koňák, J Kopeček. Biomacromolecules. 9 (2008): 510-517. [doi]
[357] Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA Copolymer-9-AC conjugate in rats. S-Q Gao, Y Sun, P Kopečková, C M Peterson, J Kopeček. Pharm. Res.. 25 (2008): 218-226. [doi]
[356] Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugs. J Hongrapipat, P Kopečková, S Prakongpan, J Kopeček. Int J Pharm. 351 (2008): 259-270. [doi]
[355] Multifunctional water-soluble polymers for drug delivery. H Pan, J Kopeček. Multifunctional Pharmaceutical Nanocarriers. Ed. V P Torchilin. (2008): 81-142.
[354] Genetically Engineered Block Copolymers: Influence of the Length and Structure of the Coiled-Coil Blocks on Hydrogel Self-Assembly. C Xu, J Kopeček. Pharm. Res.. 25 (2008): 674-682. [doi]
[353] Stability in Plasmas of Various Species of HPMA Copolymer–PGE1 Conjugates. H Pan, P Kopečková, J Liu, D Wang, S C Miller, J Kopeček. Pharm. Res.. 24 (2007): 2270-2280. [doi]
[352] Hydrogel biomaterials: A smart future?. J Kopeček. Biomaterials. 28 (2007): 5185-5192. [doi]
[351] Osteotropic peptide that differentiates functional domains of the skeleton. D Wang, S C Miller, L S Shlyakhtenko, Alexander M Portillo, X-M Liu, K Papangkorn, P Kopečková, Yuri Lyubchenko, W I Higuchi, J Kopeček. Bioconjugate Chem.. 18 (2007): 1375-1378. [doi]
[350] Liberation of doxorubicin from HPMA copolymer conjugate is essential for the induction of cell cycle arrest and nuclear fragmentation in ovarian carcinoma cells. A Malugin, P Kopečková, J Kopeček. J Control Release. 124 (2007): 6-10. [doi]
[349] Self-association properties of HPMA copolymers containing an amphipathic heptapeptide. H Ding, P Kopečková, J Kopeček. J Drug Target. 15 (2007): 465-474. [doi]
[348] Polymeric biomaterials and drug delivery systems. J Kopeček. J. Jpn. Biomat. Soc.. 25 (2007): 123-135.
[347] Hydrogels as smart biomaterials. J Kopeček, J Yang. Polymer Int. 56 (2007): 1078-1098. [doi]
[346] Biodistribution and phannacokinetics of colon-specific HPMA copolymer-9-aminocamptothecin conjugate in mice. S-Q Gao, Z-R Lu, P Kopečková, J Kopeček. J Control Release. 117 (2007): 179-185. [doi]
[345] Self-Assembling Hydrogels. C Xu, J Kopeček. Polym Bull.. 58 (2007): 53-63. [doi]
[344] Using N-(2-hydroxypropyl) methacrylamide copolymer drug bioconjugate as a novel approach to deliver a Bcl-2-targeting compound HA14-1 in vivo. M Oman, J H Liu, J Chen, D Durrant, H.-S. Yang, Y He. Gene Ther Mol Biol \textbackslashldots. (2006):.
[343] Pharmacokinetic and Biodistribution Studies of a Bone-Targeting Drug Delivery System Based on N-(2-Hydroxypropyl)methacrylamide Copolymers. D Wang, M Sima, R L Mosley, J P Davda, N Tietze, S C Miller, P R Gwilt, P Kopečková, J Kopeček. Mol. Pharm. 3 (2006): 717-725. [doi]
[342] Two-Step Fluorescence Screening of CD21-Binding Peptides with One-Bead One-Compound Library and Investigation of Binding Properties of N-(2-Hydroxypropyl)methacrylamide Copolymer\textbackslashtextminusPeptide Conjugates. Hui Ding, Wolfgang M Prodinger, J and Kopeček. Biomacromolecules. 7 (2006): 3037-3046. [doi]
[341] Semitelechelic HPMA Copolymers Functionalized with Triphenylphosphonium as Drug Carriers for Membrane Transduction and Mitochondrial Localization. J Callahan, J Kopeček. Biomacromolecules. 7 (2006): 2347-2356. [doi]
[340] Refolding Hydrogels Self-Assembled from N-(2-Hydroxypropyl)methacrylamide Graft Copolymers by Antiparallel Coiled-Coil Formation. J Yang, C Xu, C Wang, J Kopeček. Biomacromolecules. 7 (2006): 1187-1195. [doi]
[339] Identification of CD21-Binding Peptides with Phage Display and Investigation of Binding Properties of HPMA Copolymer\textbackslashtextminusPeptide Conjugates. H Ding, W M Prodinger, J Kopeček. Bioconjugate Chem.. 17 (2006): 514-523. [doi]
[338] Water-soluble HPMA copolymer - prostaglandin E-1 conjugates containing a cathepsin K sensitive spacer. H Pan, P Kopečková, D Wang, J Yang, S C Miller, J Kopeček. J Drug Target. 14 (2006): 425-435. [doi]
[337] Hybrid Hydrogels Self-Assembled from HPMA Copolymers Containing Peptide Grafts. J Yang, C Xu, P Kopečková, J Kopeček. Macromol Biosci. 6 (2006): 201-209. [doi]
[336] HPMA Copolymer-Bound Doxorubicin Induces Apoptosis in Ovarian Carcinoma Cells by the Disruption of Mitochondrial Function. A Malugin, P Kopečková, J Kopeček. Mol. Pharm. 3 (2006): 351-361. [doi]
[335] Polymer-Drug Conjugates. V Cuchelkar, J Kopeček. Polymers in Drug Delivery. Ed. I F Uchegbu. (2006): 155-182.
[334] Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer. S-Q Gao, Z-R Lu, B Petri, P Kopečková, J Kopeček. J Control Release. 110 (2006): 323-331. [doi]
[333] Synthesis and characterization of novel aromatic azo bond-containing pH-sensitive and hydrolytically cleavable IPN hydrogels. P Chivukula, K Dušek, D Wang, M Dukova-Smrckova, P Kopečková, J Kopeček. Biomaterials. 27 (2006): 1140-1151. [doi]
[332] PEGylation of Poly(ethylene imine) Affects Stability of Complexes with Plasmid DNA under in Vivo Conditions in a Dose-Dependent Manner after Intravenous Injection into Mice. T Merdan, K Kunath, H Petersen, U Bakowsky, K H Voigt, J Kopeček, T Kissel. Bioconjugate Chem.. 16 (2005): 785-792. [doi]
[331] Confocal-microscopy studies of a model oligoribonucleotide HIV inhibitor. R M Hyde, K D Jensen, J Kopeček, Arthur D Broom. Nucleosides Nucleotides Nucleic Acids. 24 (2005): 1875-1884. [doi]
[330] Reversible Hydrogels from Self-Assembling Genetically Engineered Protein Block Copolymers. C Xu, V Breedveld, J Kopeček. Biomacromolecules. 6 (2005): 1739-1749. [doi]
[329] Bone-targeting macromolecular therapeutics. D Wang, S C Miller, P Kopečková, J Kopeček. Adv. Drug. Deliv. Rev.. 57 (2005): 1049-1076. [doi]
[328] Intracellular targeting of polymer-bound drugs for cancer chemotherapy. A Nori, J Kopeček. Adv. Drug. Deliv. Rev.. 57 (2005): 609-636. [doi]
[327] Biopolymer-based delivery systems for advanced imaging and skeletal tissue-specific therapeutics. S C Miller, D Wang, P Kopečková, J Kopeček. J. Bone Miner. Metab.. 23 (2005): 103-108. [doi]
[326] Drug Carriers in Medicine and Biology. Peter D Senter, J Kopeček. Mol. Pharm. 1 (2004): 395-398. [doi]
[325] Genetically Engineered Protein Motifs in the Design of Novel Polymers and Drug Delivery Systems. J Kopeček. Contemporary Topics in Advanced Polymer Science and Technology. Eds. Q F Zhou, S Z D Cheng. (2004): 374-386.
[324] The Arthrotropism of Macromolecules in Adjuvant-Induced Arthritis Rat Model: A Preliminary Study. D Wang, S C Miller, M Sima, D Parker, H Buswell, K C Goodrich, P Kopečková, J Kopeček. Pharm. Res.. 21 (2004): 1741-1749. [doi]
[323] HPMA Copolymer-Bound Doxorubicin Induces Apoptosis in Human Ovarian Carcinoma Cells by a Fas-Independent Pathway. A Malugin, P Kopečková, J Kopeček. Mol. Pharm. 1 (2004): 174-182. [doi]
[322] Cathepsin K inhibitor-polymer conjugates: potential drugs for the treatment of osteoporosis and rheumatoid arthritis. D Wang, W Li, M Pechar, P Kopečková, D Bromme, J Kopeček. Int J Pharm. 277 (2004): 73-79. [doi]
[321] Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer–doxorubicin conjugates to human colon cancer cells. A David, P Kopečková, T Minko, A Rubinstein, J Kopeček. Eur J Cancer. 40 (2004): 148-157. [doi]
[320] Synthesis and Evaluation of Water-Soluble Polymeric Bone-Targeted Drug Delivery Systems. D Wang, S Miller, M Sima, P Kopečková, J Kopeček. Bioconjugate Chem.. 14 (2003): 853-859. [doi]
[319] Swelling Pressure Induced Phase-Volume Transition in Hybrid Biopolymer Gels Caused by Unfolding of Folded Crosslinks: A Model. K Dušek, M Dušková-Smrčková, Michal Ilavský, R Stewart, J Kopeček. Biomacromolecules. 4 (2003): 1818-1826. [doi]
[318] Pegylated Polyethylenimine\textbackslashtextminusFab‘ Antibody Fragment Conjugates for Targeted Gene Delivery to Human Ovarian Carcinoma Cells. T Merdan, J Callahan, H Petersen, K Kunath, U Bakowsky, P Kopečková, T Kissel, J Kopeček. Bioconjugate Chem.. 14 (2003): 989-996. [doi]
[317] Free and N-(2-Hydroxypropyl)methacrylamide Copolymer-bound Geldanamycin Derivative Induce Different Stress Responses in A2780 Human Ovarian Carcinoma Cells. Nobuhiro Nishiyama, A Nori, Alexander Malugin, Y Kasuya, P Kopečková, J Kopeček. Cancer Res.. 63 (2003): 7876-7882. [doi]
[316] Macromolecular therapeutics: State-of-the-art and future potential. J Kopeček, P Kopečková. Bulletin technique Gattefossé. 96 (2003): 9-21.
[315] Smart and genetically engineered biomaterials and drug delivery systems. J Kopeček. Eur J Pharm Sci. 20 (2003): 1-16. [doi]
[314] Antigen Responsive Hydrogels Based on Polymerizable Antibody Fab´ Fragment. Z-R Lu, P Kopečková, J Kopeček. Macromol Biosci. 3 (2003): 296-300. [doi]
[313] Subcellular trafficking of HPMA copolymer–Tat conjugates in human ovarian carcinoma cells. A Nori, K D Jensen, M Tijerina, P Kopečková, J Kopeček. J Control Release. 91 (2003): 53-59. [doi]
[312] Mechanisms of Cytotoxicity in Human Ovarian Carcinoma Cells Exposed to Free Mce6 or HPMA Copolymer–Mce6 Conjugates. M Tijerina, P Kopečková, J Kopeček. Photochem. Photobiol.. 77 (2003): 645-652. [doi]
[311] Correlation of Subcellular Compartmentalization of HPMA Copolymer-Mce6 Conjugates with Chemotherapeutic Activity in Human Ovarian Carcinoma Cells. M Tijerina, P Kopečková, J Kopeček. Pharm. Res.. 20 (2003): 728-737. [doi]
[310] HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer. C M Peterson, J.-G. Shiah, Y Sun, P Kopečková, T Minko, R C Straight, J Kopeček. Adv. Exp. Med. Biol.. 519 (2003): 101-123.
[309] Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes. A Tang, P Kopečková, J Kopeček. Pharm. Res.. 20 (2003): 360-367. [doi]
[308] Tat-Conjugated Synthetic Macromolecules Facilitate Cytoplasmic Drug Delivery To Human Ovarian Carcinoma Cells. A Nori, K Jensen, M Tijerina, P Kopečková, J Kopeček. Bioconjugate Chem.. 14 (2003): 44-50. [doi]
[307] Cytoplasmic delivery and nuclear targeting of synthetic macromolecules. K D Jensen, A Nori, M Tijerina, P Kopečková, J Kopeček. J Control Release. 87 (2003): 89-105. [doi]
[306] Polymerizable Fab' antibody fragment targeted photodynamic cancer therapy in nude mice. Z-R Lu, J.-G. Shiah, P Kopečková, J Kopeček. STP pharma sciences. 13 (2003): 69-75.
[305] N-(2-hydroxypropyl)-methacrylamide copolymer-9-aminocamptothecin conjugate: Colon-specific drug delivery in rats. Shinji Sakuma, Z-R Lu, B Pecharova, P Kopečková, J Kopeček. J Bioact Compat Polym. 17 (2002): 305-319. [doi]
[304] Novel Aromatic Azo-Containing pH-Sensitive Hydrogels: Synthesis and Characterization. D Wang, K Dušek, P Kopečková, M Dušková-Smrčková, J Kopeček. Macromolecules. 35 (2002): 7791-7803. [doi]
[303] Antisense Oligonucleotides Delivered to the Lysosome Escape and Actively Inhibit the Hepatitis B Virus. K Jensen, P Kopečková, J Kopeček. Bioconjugate Chem.. 13 (2002): 975-984. [doi]
[302] Polymer chemistry: Swell gels. J Kopeček. Nature. 417 (2002): 388-391. [doi]
[301] Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. T Merdan, J Kopeček, T Kissel. Adv. Drug. Deliv. Rev.. 54 (2002): 715-758. [doi]
[300] Inhibition of Cathepsin K with Lysosomotropic Macromolecular Inhibitors. D Wang, M Pechar, Weijie Li, P Kopečková, D Brömme, J Kopeček. Biochemistry. 41 (2002): 8849-8859. [doi]
[299] Associative diblock copolymers of poly(ethylene glycol) and coiled-coil peptides. M Pechar, P Kopečková, L Joss, J Kopeček. Macromol Biosci. 2 (2002): 199-206. [doi]
[298] Intracellular Processing of Poly(Ethylene Imine)/Ribozyme Complexes Can Be Observed in Living Cells by Using Confocal Laser Scanning Microscopy and Inhibitor Experiments. T Merdan, K Kunath, D Fischer, J Kopeček, T Kissel. Pharm. Res.. 19 (2002): 140-146. [doi]
[297] The Influence of Fusion Sequences on the Thermal Stabilities of Coiled-Coil Proteins. C Xu, L Joss, C Wang, M Pechar, J Kopeček. Macromol Biosci. 2 (2002): 395-401. [doi]
[296] Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Yi Luo, Nicole J Bernshaw, Z-R Lu, J Kopeček, G D Prestwich. Pharm. Res.. 19 (2002): 396-402. [doi]
[295] Presentation of Epitopes on Genetically Engineered Peptides and Selection of Lymphoma-Targeting Moieties Based on Epitope Biorecognition. A Tang, J Kopeček. Biomacromolecules. 3 (2002): 421-431. [doi]
[294] The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in hep G2 cells. K D Jensen, P Kopečková, J H Bridge, J Kopeček. AAPS PharmSci. 3 (2002): 62-75. [doi]
[293] Design of novel bioconjugates for targeted drug delivery. Z-R Lu, J.-G. Shiah, Shinji Sakuma, P Kopečková, J Kopeček. J Control Release. 78 (2002): 165-173. [doi]
[292] Influence of the structure of drug moieties on the in vitro efficacy of HPMA copolymer-geldanamycin derivative conjugates. Y Kasuya, Z-R Lu, P Kopečková, S E Tabibi, J Kopeček. Pharm. Res.. 19 (2002): 115-123. [doi]
[291] The Role of Galactose, Lactose, and Galactose Valency in the Biorecognition of N-(2-Hydroxypropyl)Methacrylamide Copolymers by Human Colon Adenocarcinoma Cells. A David, P Kopečková, J Kopeček, A Rubinstein. Pharm. Res.. 19 (2002): 1114-1122. [doi]
[290] Poly[N-(2-hydroxypropyl)methacrylamide-block-n-butyl acrylate] micelles in water/DMF mixed solvents. Č Koňák, B Ganchev, M Teodorescu, K Matyjaszewski, P Kopečková, J Kopeček. Polymer. 43 (2002): 3735-3741. [doi]
[289] Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin. Shinji Sakuma, Z-R Lu, P Kopečková, J Kopeček. J Control Release. 75 (2001): 365-379. [doi]
[288] Enhanced Biorecognition and Internalization of HPMA Copolymers Containing Multiple or Multivalent Carbohydrate Side-Chains by Human Hepatocarcinoma Cells. A David, P Kopečková, A Rubinstein, J Kopeček. Bioconjugate Chem.. 12 (2001): 890-899. [doi]
[287] Hybrid Hydrogels Cross-Linked by Genetically Engineered Coiled-Coil Block Proteins. C Wang, J Kopeček, R J Stewart. Biomacromolecules. 2 (2001): 912-920. [doi]
[286] Potential of lectin-N-(2-hydroxypropyl)methacrylamide copolymer-drug conjugates for the treatment of pre-cancerous conditions. S Wróblewski, M M Berenson, P Kopečková, J Kopeček. J Control Release. 74 (2001): 283-293. [doi]
[285] Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer–doxorubicin/mesochlorin e6-OV-TL 16 antibody immunoconjugates. J.-G. Shiah, Y Sun, P Kopečková, C M Peterson, R C Straight, J Kopeček. J Control Release. 74 (2001): 249-253. [doi]
[284] Water-soluble HPMA copolymer-wortmannin conjugate retains phosphoinositide 3-kinase inhibitory activity in vitro and in vivo. L Varticovski, Z-R Lu, K Mitchell, Isabel de Aos, J Kopeček. J Control Release. 74 (2001): 275-281. [doi]
[283] Preparation of Fab' from Murine IgG2a for Thiol Reactive Conjugation. K D Fowers, J Callahan, Parke Byron, JindřIch ich Kopeček. J Drug Target. 9 (2001): 281-294. [doi]
[282] Improved synthesis and evaluation of 17-substituted aminoalkylgeldanamycin derivatives applicable to drug delivery systems. Y Kasuya, Z-R Lu, P Kopečková, J Kopeček. Bioorg. Med. Chem. Lett.. 11 (2001): 2089-2091. [doi]
[281] The effects of subcellular localization of N-(2-hydroxypropyl)methacrylamide copolymer-Mce6 conjugates in a human ovarian carcinoma. M Tijerina, P Kopečková, J Kopeček. J Control Release. 74 (2001): 269-273. [doi]
[280] A model for swelling changes in a covalently crosslinked gel caused by unfolding of folded domains. K Dušek, M Dušková-Smrčková, R J Stewart, J Kopeček. Polym Bull.. 47 (2001): 351-358. [doi]
[279] Preparation and biological evaluation of polymerizable antibody Fab´ fragment targeted polymeric drug delivery system. Z-R Lu, J.-G. Shiah, P Kopečková, J Kopeček. J Control Release. 74 (2001): 263-268. [doi]
[278] Synthesis and characterization of HPMA copolymer–aminopropylgeldanamycin conjugates. Y Kasuya, Z-R Lu, P Kopečková, T Minko, S E Tabibi, J Kopeček. J Control Release. 74 (2001): 203-211. [doi]
[277] Water soluble polymers in tumor targeted delivery. J Kopeček, P Kopečková, T Minko, Z-R Lu, C M Peterson. J Control Release. 74 (2001): 147-158. [doi]
[276] De novo design of biomedical polymers: hybrids from synthetic macromolecules and genetically engineered protein domains. J Kopeček, A Tang, C Wang, R J Stewart. Macromol. Symp.. 174 (2001): 31-42. [doi]
[275] The Influence of a Colonic Microbiota on HPMA Copolymer Lectin Conjugates Binding in Rodent Intestine. S Wróblewski, B R̆íhová, P Rossmann, T Hudcovicz, Z Rehakova, P Kopečková, J Kopeček. J Drug Target. 9 (2001): 85-94. [doi]
[274] Modification of cyclosporin A and conjugation of its derivative to HPMA copolymers. Z-R Lu, S-Q Gao, P Kopečková, J Kopeček. Bioconjugate Chem.. 12 (2001): 129-133. [doi]
[273] Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. T Minko, P Kopečková, J Kopeček. J Control Release. 71 (2001): 227-237. [doi]
[272] Biodistribution and antitumour efficacy of long-circulating N-(2-hydroxypropyl)methacrylamide copolymer–doxorubicin conjugates in nude mice. J.-G. Shiah, M Dvorak, P Kopečková, Y Sun, C M Peterson, J Kopeček. Eur J Cancer. 37 (2001): 131-139. [doi]
[271] The coiled coils in the design of protein-based constructs: hybrid hydrogels and epitope displays. A Tang, C Wang, R J Stewart, J Kopeček. J Control Release. 72 (2001): 57-70. [doi]
[270] Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin. T Minko, P Kopečková, J Kopeček. Macromol. Symp.. 172 (2001): 35-48. [doi]
[269] Semitelechelic Poly[N-(2-hydroxypropyl)methacrylamide] for Biomedical Applications. Z-R Lu, P Kopečková, J Kopeček. Polymeric Drugs & Delivery Systems. Eds. R M Ottenbrite, S-W Kim. Technomics Publishing Co. (2001): 1-14.
[268] Genetically Engineered Protein Domain as Crosslinks in Hydrogels. C Wang, R J Stewart, J Kopeček. Polymeric Drugs & Delivery Systems. Eds. R M Ottenbrite, S-W Kim. (2001): 131-143.
[267] Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance. M Tijerina, K D Fowers, P Kopečková, J Kopeček. Biomaterials. 21 (2000): 2203-2210. [doi]
[266] Synthesis of Starlike N-(2-Hydroxypropyl)methacrylamide Copolymers: Potential Drug Carriers\textbackslashdag. D Wang, P Kopečková, T Minko, V Nanayakkara, J Kopeček. Biomacromolecules. 1 (2000): 313-319. [doi]
[265] Responsive Hybrid Hydrogels with Volume Transitions Modulated by a Titin Immunoglobulin Module. L Chem, J Kopeček, R Stewart. Bioconjugate Chem.. 11 (2000): 734-740. [doi]
[264] Biorecognition of HPMA copolymer–lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues. S Wróblewski, M M Berenson, P Kopečková, J Kopeček. J. Biomed. Mater. Res.. 51 (2000): 329-342. [doi]
[263] Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. M Demoy, T Minko, P Kopečková, J Kopeček. J Control Release. 69 (2000): 185-196. [doi]
[262] HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action. J Kopeček, P Kopečková, T Minko, Z-R Lu. Eur J Pharm Biopharm. 50 (2000): 61-81. [doi]
[261] The Influence of Cytotoxicity of Macromolecules and of VEGF Gene Modulated Vascular Permeability on the Enhanced Permeability and Retention Effect in Resistant Solid Tumors. T Minko, P Kopečková, Vitaliy Pozharov, K D Jensen, J Kopeček. Pharm. Res.. 17 (2000): 505-514. [doi]
[260] Self-Assembled Peptides Exposing Epitopes Recognizable by Human Lymphoma Cells. A Tang, C Wang, R Stewart, J Kopeček. Bioconjugate Chem.. 11 (2000): 363-371. [doi]
[259] Synthesis of bioadhesive lectin-HPMA copolymer-cyclosporin conjugates. Z-R Lu, S-Q Gao, P Kopečková, J Kopeček. Bioconjugate Chem.. 11 (2000): 3-7. [doi]
[258] Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. T Minko, P Kopečková, J Kopeček. Int. J. Cancer. 86 (2000): 108-117. [doi]
[257] HPMA copolymer-modified avidin: Immune response. P R Hart, P Kopečková, V Omelyanenko, E Enioutina, J Kopeček. J Biomater Sci Polym Ed. 11 (2000): 1-12. [doi]
[256] Antitumor Activity of N-(2-Hydroxypropyl)methacrylamide Copolymer-Mesochlorin e6 and Adriamycin Conjugates in Combination Treatments. J.-G. Shiah, Y Sun, C M Peterson, R C Straight, J Kopeček. Clin. Cancer Res.. 6 (2000): 1008-1015. [doi]
[255] Photodynamic cross-linking of proteins: V. Nature of the tyrosine–tyrosine bonds formed in the FMN-sensitized intermolecular cross-linking of N-acetyl-L-tyrosine. H.-R. Shen, J D Spikes, C J Smith, J Kopeček. J Photochem Photobiol A Chem. 133 (2000): 115-122. [doi]
[254] HPMA copolymer–anticancer drug–OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound Adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line. K Kunath, P Kopečková, T Minko, J Kopeček. Eur J Pharm Biopharm. 49 (2000): 11-15. [doi]
[253] Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and mesochlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro. J M Lu, C M Peterson, J Guo-Shiah, Z-W Gu, C A Peterson, R C Straight, J Kopeček. Int. J. Oncol.. 15 (1999): 5-16.
[252] Synthesis of HPMA copolymer containing adriamycin bound via an acid-labile spacer and its activity toward human ovarian carcinoma cells. W-M Choi, P Kopečková, T Minko, J Kopeček. J Bioact Compat Polym. 14 (1999): 447-456.
[251] Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e6 and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. J.-G. Shiah, Y Sun, C M Peterson, J Kopeček. J Control Release. 61 (1999): 145-157. [doi]
[250] Polymerizable Fab' antibody fragments for targeting of anticancer drugs. Z-R Lu, P Kopečková, J Kopeček. Nat. Biotechnol.. 17 (1999): 1101-1104.
[249] High-molecular weight HPMA copolymer–adriamycin conjugates. M Dvorak, P Kopečková, J Kopeček. J Control Release. 60 (1999): 321-332. [doi]
[248] Photodynamic cross-linking of proteins: IV. Nature of the His–His bond(s) formed in the rose bengal-photosensitized cross-linking of N-benzoyl-L-histidine. H.-R. Shen, J D Spikes, C J Smith, J Kopeček. J Photochem Photobiol A Chem. 130 (1999): 1-6. [doi]
[247] Synthesis of semitelechelic poly[N-(2-hydroxypropyl)methacryl-amide] by radical polymerization in the presence of alkyl mercaptans. Z-R Lu, P Kopečková, Z Wu, J Kopeček. Macromol Chem Phys. 200 (1999): 2022-2030. [doi]
[246] Comparison of the Anticancer Effect of Free and HPMA Copolymer-Bound Adriamycin in Human Ovarian Carcinoma Cells. T Minko, P Kopečková, J Kopeček. Pharm. Res.. 16 (1999): 986-996. [doi]
[245] Biorecognition of HPMA Copolymer-Adriamycin Conjugates by Lymphocytes Mediated by Synthetic Receptor Binding Epitopes. V Omelyanenko, P Kopečková, R K Prakash, C D Ebert, J Kopeček. Pharm. Res.. 16 (1999): 1010-1019. [doi]
[244] Photodynamic crosslinking of proteins. III. Kinetics of the FMN- and rose bengal-sensitized photooxidation and intermolecular crosslinking of model tyrosine-containing N-(2-hydroxypropyl)methacrylamide copolymers. J D Spikes, H.-R. Shen, P Kopečková, J Kopeček. Photochem. Photobiol.. 70 (1999): 130-137. [doi]
[243] Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains. C Wang, R J Stewart, J Kopeček. Nature. 397 (1999): 417-420. [doi]
[242] Degradation and Aggregation of Human Calcitonin In Vitro. Richard H Lu, P Kopečková, J Kopeček. Pharm. Res.. 16 (1999): 359-367. [doi]
[241] Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. T Minko, P Kopečková, J Kopeček. J Control Release. 59 (1999): 133-148. [doi]
[240] Functionalized semitelechelic poly(N-(2-hydroxypropyl)methacrylamide) for protein modification. Z-R Lu, P Kopečková, Z Wu, J Kopeček. Bioconjugate Chem.. 9 (1998): 793-804. [doi]
[239] Micellization of Graft Copolymers of Alkyl Methacrylates with α-Methyl-\$ømega\$-hydroxypoly(oxyethylene) Methacrylates. C Konák, M Helmstedt, P Kopečková, J Kopeček. J Colloid Interface Sci. 208 (1998): 252-258. [doi]
[238] Photoassociation of water-soluble copolymers containing photochromic spirobenzopyran moieties. Č Koňák, R C Rathi, P Kopečková, J Kopeček. Polym Adv Technol. 9 (1998): 641-648. [doi]
[237] Lectin-HPMA copolymer conjugates: potential oral drug carriers for targeting diseased tissues. S Wróblewski, P Kopečková, B R̆íhová, J Kopeček. Macromol Chem Phys. 199 (1998): 2601-2608. [doi]
[236] Novel pH-sensitive hydrogels with adjustable swelling kinetics. Emmanuel O Akala, P Kopečková, J Kopeček. Biomaterials. 19 (1998): 1037-1047. [doi]
[235] Influence of pH on aggregation and photoproperties of n-(2-hydroxypropyl)methacrylamide copolymer–meso-chlorin e6 conjugates. J.-G. Shiah, C Konák, J D Spikes, J Kopeček. . 5 (1998): 119-126. [doi]
[234] HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. T Minko, P Kopečková, V Pozharov, J Kopeček. J Control Release. 54 (1998): 223-233. [doi]
[233] HPMA-copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. V Omelyanenko, C Gentry, P Kopečková, J Kopeček. Int. J. Cancer. 75 (1998): 600-608. [doi]
[232] Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. V Omelyanenko, P Kopečková, C Gentry, J Kopeček. J Control Release. 53 (1998): 25-37. [doi]
[231] Biorecognizable Polymers: Design, Structure, and Bioactivity. J Kopeček, P Kopečková, C Konák. J. Macromol. Sci., Pure Appl. Chem.. 34 (1997): 2103-2117. [doi]
[230] Solution and Photoproperties of N-(2-Hydroxypropyl)methacrylamide Copolymer\textbackslashtextminusMeso-chlorin e6 Conjugates. J.-G. Shiah, Č Koňák, J D Spikes, J Kopeček. J. Phys. Chem. B. 101 (1997): 6803-6809. [doi]
[229] Photoregulated Association of Water-Soluble Copolymers with Spirobenzopyran-Containing Side Chains. Č Koňák, Ramesh C Rathi, P Kopečková, J Kopeček. Macromolecules. 30 (1997): 5553-5556. [doi]
[228] Development of a fibrinolytic surface: specific and non-specific binding of plasminogen. K D Fowers, J Kopeček. Colloids Surf B Biointerfaces. 9 (1997): 315-330. [doi]
[227] Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium. H Ghandehari, P L Smith, H Ellens, P.-Y. Yeh, J Kopeček. J. Pharmacol. Exp. Ther.. 280 (1997): 747-753.
[226] In vitro degradation of pH-sensitive hydrogels containing aromatic azo bonds. H Ghandehari, P Kopečková, J Kopeček. Biomaterials. 18 (1997): 861-872. [doi]
[225] Biorecognition of sugar containing N-(2-hydroxypropyl)methacrylamide copolymers by immobilized lectin. R C Rathi, P Kopečková, J Kopeček. Macromol Chem Phys. 198 (1997): 1165-1180. [doi]
[224] Lysosomal degradability of poly(alpha-amino acids). H-C Chiu, P Kopečková, S S Deshmane, J Kopeček. J. Biomed. Mater. Res.. 34 (1997): 381-392. [doi]
[223] Intracellularly biorecognizable derivatives of 5-fluorouracil: Implications for site-specific delivery in the human condition. D A Putnam, J.-G. Shiah, J Kopeček. Biochem. Pharmacol.. 52 (1996): 957-962. [doi]
[222] Photodynamic crosslinking of proteins II. Photocrosslinking of a model protein-ribonuclease A. H.-R. Shen, J D Spikes, P Kopečková, J Kopeček. J. Photochem. Photobiol. B, Biol.. 35 (1996): 213-219. [doi]
[221] Photodynamic crosslinking of proteins. I. Model studies using histidine- and lysine-containing N-(2-hydroxypropyl) methacrylamide copolymers. H.-R. Shen, J D Spikes, P Kopečková, J Kopeček. J. Photochem. Photobiol. B, Biol.. 34 (1996): 203-210. [doi]
[220] Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl)methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. C M Peterson, J M Lu, Y Sun, C A Peterson, J.-G. Shiah, R C Straight, J Kopeček. Cancer Res.. 56 (1996): 3980-3985.
[219] HPMA Copolymer-Anticancer Drug-OV-TL16 Antibody Conjugates. 1. Influence of the Method of Synthesis on the Binding Affinity to OVCAR-3 Ovarian Carcinoma Cells in Vitro. V Omelyanenko, P Kopečková, C Gentry, J.-G. Shiah, J Kopeček. J Drug Target. 3 (1996): 357-373. [doi]
[218] Biorecognizable Biomedical Polymers. J Kopeček, P Kopečková, V Omelyanenko. Advances in Biomedical Polymers in Biomedical Engineering and Drug Delivery Systems. Eds. N Ogata, S-W Kim, J Feijen, T Okano. (1996): 91-95.
[217] Biodegradable and pH sensitive hydrogels: synthesis by a polymer-polymer reaction. H Ghandehari, P Kopečková, P.-Y. Yeh, J Kopeček. Macromol Chem Phys. 197 (1996): 965-980. [doi]
[216] Isobolographic Assessment of the Interaction Between Adriamycin and Photodynamic Therapy With Meso-Chlorin e6 Monoethylene Diamine in Human Epithelial Ovarian Carcinoma (OVCAR-3) In Vitro. C M Peterson, M L Jing, G Zhong-wei, S Jane-Guo, K Lythgoe, C A Peterson, R C Straight, J Kopeček. J. Soc. Gynecol. Investig.. 2 (1995): 772-777. [doi]
[215] Enantioselective Release of 5-Fluorouracil from N-(2-Hydroxypropyl)methacrylamide-Based Copolymers via Lysosomal Enzymes. D Putnam, J Kopeček. Bioconjugate Chem.. 6 (1995): 483-492. [doi]
[214] Association of a Substituted Zinc(II) Phthalocyanine-N- (2-Hydroxypropyl)methacrylamide Copolymer Conjugate. Z-W Gu, V Omelyanenko, P Kopečková, J Kopeček, Č Koňák. Macromolecules. 28 (1995): 8375-8380. [doi]
[213] Association of Graft Copolymers of Alkyl Methacrylates with α-Methyl-\$ømega\$-hydroxy-poly(oxyethylene) ethacrylates. Č Koňák, Z Tuzar, P Kopečková, J D Andrade, J Kopeček. CCCC. 60 (1995): 1971-1985. [doi]
[212] Degradability of hydrogels containing azoaromatic crosslinks. P.-Y. Yeh, P Kopečková, J Kopeček. Macromol Chem Phys. 196 (1995): 2183-2202. [doi]
[211] Prolonged Blood Circulation in Rats of Nanospheres Surface-Modified with Semitelechelic Poly[N-(2-Hydroxypropyl)methacrylamide]. S Kamei, J Kopeček. Pharm. Res.. 12 (1995): 663-668. [doi]
[210] Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. P.-Y. Yeh, M M Berenson, W S Samowitz, P Kopečková, J Kopeček. J Control Release. 36 (1995): 109-124. [doi]
[209] Polymer conjugates with anticancer activity. D A Putnam, J Kopeček. Advances in Polymer Science; Biopolymers II. Eds. N A Peppas, R S Langer. (1995): 55-123.
[208] Enzymatic Degradation of Poly(ethylene glycol) Modified Dextrans. H-C Chiu, Č Koňák, P Kopečková, J Kopeček. J Bioact Compat Polym. 9 (1994): 388-410. [doi]
[207] Photoregulated Adsorption and Association of Amphiphilic Copolymers Containing Azobenzene Side Chains. Č Koňák, P Kopečková, J Kopeček. J Colloid Interface Sci. 168 (1994): 235-241. [doi]
[206] Solution Properties of Polymers Containing Zwitterionic Moieties in Side Chains. Č Koňák, R C Rathi, P Kopečková, J Kopeček. Macromolecules. 27 (1994): 1992-1996. [doi]
[205] Biodegradable and pH-sensitive hydrogels: Synthesis by crosslinking of N,N-dimethylacrylamide copolymer precursors. P.-Y. Yeh, P Kopečková, J Kopeček. J Polym Sci A Polym Chem. 32 (1994): 1627-1637. [doi]
[204] Adsorption and activation of zymogens at solid-liquid interfaces: I. Chymotrypsinogen on alkylamino modified silica derivatives. H.-R. Yen, Sven Oscarsson, K Ulbrich, J Kopeček. J. Biomed. Mater. Res.. 28 (1994): 247-257. [doi]
[203] Bioadhesive N-(2-hydroxypropyl)methacrylamide copolymers for colon-specific drug delivery. P Kopečková, R C Rathi, S Takada, B R̆íhová, M M Berenson, J Kopeček. J Control Release. 28 (1994): 211-222. [doi]
[202] A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. N L Krinick, Y Sun, D Joyner, J D Spikes, R C Straight, J Kopeček. J Biomater Sci Polym Ed. 5 (1994): 303-324. [doi]
[201] Synthesis and Photoproperties of a Substituted Zinc(II) Phthalocyanine-\textitN-(2-hydroxypropyl)methacrylamide Copolymer Conjugate. Z-W Gu, J D Spikes, P Kopečková, J Kopeček. CCCC. 58 (1993): 2321-2336. [doi]
[200] Enzymatic activity of chymotrypsin and its poly(ethylene glycol) conjugates toward low and high molecular weight substrates. H-C Chiu, S Zalipsky, P Kopečková, J Kopeček. Bioconjugate Chem.. 4 (1993): 290-295. [doi]
[199] Photoproperties of a mesochlorin e6—N-(2-hydroxypropyl)methacrylamide copolymer conjugate. J D Spikes, N L Krinick, J Kopeček. J Photochem Photobiol A Chem. 70 (1993): 163-170. [doi]
[198] Effect of side-chains on solution properties of N-(2-hydroxypropyl)methacrylamide copolymers in aqueous solvents. Č Koňák, R C Rathi, P Kopečková, J Kopeček. Polymer. 34 (1993): 4767-4773. [doi]
[197] Targetable photoactivatable drugs: 3. In vitro efficacy of polymer bound chlorin e-6 toward human hepatocarcinoma cell line (PLC/PRF/5) targeted with galactosamine and to mouse splenocytes targeted with anti-Thy 1.2 antibodies. B R̆íhová, N L Krinick, J Kopeček. J Control Release. 25 (1993): 71-87. [doi]
[196] Degradation of proteins by guinea pig intestinal enzymes. K Ikesue, P Kopečková, J Kopeček. Int J Pharm. 95 (1993): 171-179. [doi]
[195] In vitro bioadhesion of carbohydrate-containing N-(2-hydroxypropyl) methacrylamide copolymers to the GI tract of guinea pigs. B Rihova, R C Rathi, P Kopečková, J Kopeček. Int J Pharm. 87 (1992): 105-116.
[194] Photoregulated association of N-(2-hydroxypropyl)methacrylamide copolymers with azobenzene-containing side chains. Č Koňák, P Kopečková, J Kopeček. Macromolecules. 25 (1992): 5451-5456. [doi]
[193] Hydrogels for Site-Specific Drug Delivery to the Colon: In Vitro and in Vivo Degradation. Helle Brøndsted, J Kopeček. Pharm. Res.. 9 (1992): 1540-1545. [doi]
[192] N-(2-Hydroxypropyl)methacrylamide Copolymers for Colon Specific Drug Delivery. J Kopeček, P Kopečková. Oral Colon-Specific Delivery. Ed. D R Friend. (1992): 189-211.
[191] Cleavage of oligopeptide p-nitroanilides attached to N-(2-hydroxypropyl)methacrylamide copolymers by guinea pig intestinal enzymes. P Kopečková, K Ikesue, J Kopeček. Die Makromolekulare Chemie. 193 (1992): 2605-2619. [doi]
[190] pH Sensitive Hydrogels: Characteristics and Potential in Drug Delivery. H Brøndsted, J Kopeček. Polyelectrolyte Gels. Eds. R S Harland, R K Prudhomme. (1992): 285-304.
[189] Polymers for colon-specific drug delivery. J Kopeček, P Kopečková, H Brøndsted, R C Rathi, B R̆íhová, P.-Y. Yeh, K Ikesue. J Control Release. 19 (1992): 121-130. [doi]
[188] Optically controlled ligand delivery: 3. Photocleavage of 2-nitrobenzyl bonds at solid-liquid interfaces. H.-R. Yen, J D Andrade, J Kopeček. Polymer. 33 (1992): 1763-1767. [doi]
[187] Evaluation of protein-N-(2-hydroxypropyl) methacrylamide copolymer conjugates as targetable drug-carriers. 2. Body distribution of conjugates containing transferrin, antitransferrin receptor antibody or anti-Thy 1.2 antibody and effectiveness of transferrin-containing daunomycin conjugates against mouse L1210 leukaemia in vivo. P A Flanagan, R Duncan, V Šubr, K Ulbrich, P Kopečková, J Kopeček. J Control Release. 18 (1992): 25-38. [doi]
[186] Controlled release of LHRH-DT from bioerodible hydrogel microspheres. M Singh, R C Rathi, A Singh, J Heller, G P Talwar, J Kopeček. Int J Pharm. 76 (1991): R5-R8. [doi]
[185] Optically controlled ligand delivery. II. Copolymers containing α-methylphenacyl bonds. H.-R. Yen, J D Andrade, J Kopeček. J Appl Polym Sci. 43 (1991): 1241-1252. [doi]
[184] N-(2-hydroxypropyl) methacrylamide copolymers containing pendant saccharide moieties: Synthesis and bioadhesive properties. R C Rathi, P Kopečková, B R̆íhová, J Kopeček. J Polym Sci A Polym Chem. 29 (1991): 1895-1902. [doi]
[183] Intraperitoneal and subcutaneous retention of a soluble polymeric drug-carrier bearing galactose. L W Seymour, R Duncan, V Chytrý, J Strohalm, K Ulbrich, J Kopeček. J Control Release. 16 (1991): 255-262. [doi]
[182] Hydrogels for site-specific oral drug delivery: synthesis and characterization. H Brøndsted, J Kopeček. Biomaterials. 12 (1991): 584-592. [doi]
[181] Enzymatic degradation and immunogenic properties of derivatized dextrans. B Crepon, J Jozefonvicz, V Chytrý, B R̆íhová, J Kopeček. Biomaterials. 12 (1991): 550-554. [doi]
[180] Targetable polymeric anticancer drugs: Temporal control of drug activity. J Kopeček. Ann NY Acad Sci. 618 (1991): 335-344.
[179] Targetable photoactivatable polymeric drugs. J Kopeček, B R̆íhová, N L Krinick. J Control Release. 16 (1991): 137-144. [doi]
[178] Release of p-nitroaniline from oligopeptide side chains attached to N-(2-hydroxypropyl)methacrylamide copolymers during incubation with rat intestinal brush border enzymes. P Kopečková, M A Longer, J F Woodley, R Duncan, J Kopeček. Makromol. Chem. Rapid Commun.. 12 (1991): 101-106. [doi]
[177] Bioadhesive Water-Soluble Polymeric Drug Carriers for Site-Specific Oral Drug Delivery. Y Grim, J Kopeček. New Polymeric Mat.. 3 (1991): 49-59.
[176] Soluble Polymers as Targetable Drug Carriers. N L Krinick, J Kopeček. Handbook of Experimental Pharmacology, Vol. 100, Targeted Drug Delivery. Ed. R L Juliano. (1991): 105-179.
[175] Hydrogels for site-specific oral delivery. Poly[(acrylic acid)-co-(butyl acrylate)] crosslinked with 4,4´-bis(methacryloylamino)azobenzene. Martin Přádný, J Kopeček. Die Makromolekulare Chemie. 191 (1990): 1887-1897. [doi]
[174] Release of 5-aminosalicylic acid from bioadhesive N-(2-hydroxypropyl)methacrylamide copolymers by azoreductases in vitro. P Kopečková, J Kopeček. Die Makromolekulare Chemie. 191 (1990): 2037-2045. [doi]
[173] Release of macromolecules and daunomycin from hydrophilic gels containing enzymatically degradable bonds. V Šubr, R Duncan, J Kopeček. J Biomater Sci Polym Ed. 1 (1990): 261-278. [doi]
[172] Targetable photoactivatable drugs, 2. Synthesis of N-(2-hydroxypropyl)methacrylamide copolymeranti-thy 1.2 antibody-chlorin e6 conjugates and a preliminary study of their photodynamic effect on mouse splenocytes in vitro. N L Krinick, B R̆íhová, K Ulbrich, J Strohalm, J Kopeček. Die Makromolekulare Chemie. 191 (1990): 839-856. [doi]
[171] Immunosensors: Remaining Problems in the Development of Remote, Continuous, Multi-Channel Devices. J D Andrade, J N Lin, V Hlady, J Herron, D Christensen, J Kopeček. Biosensor Technology. Ed. R B Buck. (1990): 219-239.
[170] The Influence of Poly(Ethylene Oxide) Spacers on the Covalent and Non-Specific Binding of Immunoglobulin G to Silica Surfaces. P Kopečková, J Kopeček, J D Andrade. New Polymeric Mat.. 1 (1990): 289-297.
[169] Surface properties of copolymers of alkyl methacrylates with, methoxy (polyethylene oxide) metiiacrylates and their application as protein-resistant coatings. Jin Ho Lee, P Kopečková, J Kopeček, J D Andrade. Biomaterials. 11 (1990): 455-464. [doi]
[168] Immunogenicity of Protein-N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates in A/J and B10 Mice. P A Flanagan, R Duncan, B R̆íhová, V Šubr, J Kopeček. J Bioact Compat Polym. 5 (1990): 151-166. [doi]
[167] The pharmacokinetics of polymer-bound adriamycin. L W Seymour, K Ulbrich, J Strohalm, J Kopeček, R Duncan. Biochem. Pharmacol.. 39 (1990): 1125-1131. [doi]
[166] The potential of water-soluble polymeric carriers in targeted and site-specific drug delivery. J Kopeček. J Control Release. 11 (1990): 279-290. [doi]
[165] Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model. J Cassidy, R Duncan, G J Morrison, J Strohalm, D Plocová, J Kopeček, S B Kaye. Biochem. Pharmacol.. 38 (1989): 875-879.
[164] Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates. Pauline A Flanagan, Pavla Kopec\textbackslashv ková, Jindr\textbackslashv ich Kopec\textbackslashv ek, R Duncan. Biochim. Biophys. Acta. 993 (1989): 83-91. [doi]
[163] Effect of galactose on interaction of N-(2-hydroxypropyl)methacrylamide copolymers with hepatoma cells in culture: Preliminary application to an anticancer agent, daunomycin. Kathryn B O'Hare, I C Hume, Lynne Scarlett, V Chytrý, P Kopečková, J Kopeček, R Duncan. Hepatology. 10 (1989): 207-214. [doi]
[162] Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants. Jin Ho Lee, J Kopeček, J D Andrade. J. Biomed. Mater. Res.. 23 (1989): 351-368. [doi]
[161] Investigation of the aminolysis of p-nitrophenyl esters of (meth)acryloylaminophenoxyacetic acids and their copolymers with N-(2-hydroxypropyl)methacrylamide by 6-aminopenicillanic acid. M V Solovskij, K Ulbrich, O V Nazarova, N V Zubko, E F Panarin, J Kopeček. Die Makromolekulare Chemie. 190 (1989): 2245-2254. [doi]
[160] Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycinImmunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. B R̆íhová, M Bilej, V Vĕtvicka, K Ulbrich, J Strohalm, J Kopeček, R Duncan. Biomaterials. 10 (1989): 335-342. [doi]
[159] Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycin. B R̆íhová, K Veres, L Fornusek, K Ulbrich, J Strohalm, V Vĕtvicka, M Bilej, J Kopeček. J Control Release. 10 (1989): 37-49. [doi]
[158] Action of polymeric prodrugs based on N-(2 hydroxypropylmethacrylamide) copolymers I. Suppression of the antibody response and proliferation of mouse splenocytes in vitro. B R̆íhová, V Vĕtvicka, J Strohalm, K Ulbrich, J Kopeček. J Control Release. 9 (1989): 21-32. [doi]
[157] Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo. R Duncan, I C Hume, P Kopečková, K Ulbrich, J Strohalm, J Kopeček. J Control Release. 10 (1989): 51-64. [doi]
[156] Osmotic opening of the blood-brain barrier permeability to N-(2-hydroxypropyl)methacrylamide copolymers. Effect of polymer MW charge and hydrophobicity. B K Armstrong, Q Smith, S I Rapoport, J Strohalm, J Kopeček, R Duncan. J Control Release. 10 (1989): 27-36. [doi]
[155] Optically controlled ligand delivery, 1. Synthesis of water-soluble copolymers containing photocleavable bonds. H.-R. Yen, J Kopeček, J D Andrade. Die Makromolekulare Chemie. 190 (1989): 69-82. [doi]
[154] Soluble Synthetic Polymers for Targeting and Controlled Release of Anticancer Agents, Particularly Anthracycline Antibiotics. R Duncan, L W Seymour, K Ulbrich, J Kopeček. J Bioact Compat Polym. 3 (1988): 4-15. [doi]
[153] Targetable Photoactivatable Drugs. 1. Synthesis Of Water-Soluble Galactosamine Containing Polymeric Carriers Of Chlorin e6 And Their Photodynamic Effect On Plc Cells In Vitro. N L Krinick, B R̆íhová, K Ulbrich, J D Andrade, J Kopeček. Proc. SPIE. 997 (1988): 70-83. [doi]
[152] Cleavage of oligopeptide side-chains in N-(2-hydroxypropyl)meth-acrylamide copolymers by mixtures of lysosomal enzymes. V Šubr, J Kopeček, J Pohl, M Baudyš, V Kostka. J Control Release. 8 (1988): 133-140. [doi]
[151] On-line sensors for coagulation proteins: concept and progress report. J D Andrade, J Herron, J N Lin, H.-R. Yen, J Kopeček, P Kopečková. Biomaterials. 9 (1988): 76-79. [doi]
[150] Development of Tailor-Made Polymeric Prodrugs for Systemic and Oral Delivery. J Kopeček. J Bioact Compat Polym. 3 (1988): 16-26. [doi]
[149] Soluble N-(2-hydroxypropyl) methacrylamide copolymers as a potential oral, controlled-release, drug delivery system. I. Bioadhesion to the rat intestine in vitro. J F Bridges, J F Woodley, R Duncan, J Kopeček. Int J Pharm. 44 (1988): 213-224. [doi]
[148] Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody. B R̆íhová, P Kopečková, J Strohalm, P Rossmann, V Vĕtvicka, J Kopeček. Clin. Immunol. Immunopathol.. 46 (1988): 100-114. [doi]
[147] Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.. R Duncan, P Kopečková, J Strohalm, I C Hume, J B Lloyd, J Kopeček. Br. J. Cancer. 57 (1988): 147.
[146] The role of water at the permeation of non-electrolytes through hydrophilic membranes. H Braselmann, D Kirstein, J Vacík, J Kopeček. Acta Polymerica. 38 (1987): 196-199. [doi]
[145] Targetable polymeric prodrugs. J Kopeček, R Duncan. J Control Release. 6 (1987): 315-328. [doi]
[144] Solution properties of drug carriers based on poly[N-(2-hydroxypropyl)methacrylamide] containing biodegradable bonds. K Ulbrich, Č Koňák, Z Tuzar, J Kopeček. Die Makromolekulare Chemie. 188 (1987): 1261-1272. [doi]
[143] Copolymers of 6-O-Methacryloyl-D-Galactose and N-(2-Hydroxypropyl)methacrylamide: Targeting to Liver after Intravenous Administration to Rats. V Chytrý, J Kopeček, E Leibnitz, K B O'Hare, L Scarlett, R Duncan. New Polymeric Mat.. 1 (1987): 21-28.
[142] Polymer-bound derivatives of sarcolysin and their antitumour activity against mouse and human leukaemia in vitro. K Ulbrich, E I Zacharieva, J Kopeček, I C Hume, R Duncan. Die Makromolekulare Chemie. 188 (1987): 2497-2509. [doi]
[141] Potential of Sugar Residues Attached to N-(2- Hydroxypropyl)methacryl amide Copolymers as Targeting Groups for the Selective Delivery of Drugs. L W Seymour, R Duncan, P Kopečková, J Kopeček. J Bioact Compat Polym. 2 (1987): 97-119. [doi]
[140] Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. L W Seymour, R Duncan, J Strohalm, J Kopeček. J. Biomed. Mater. Res.. 21 (1987): 1341-1358. [doi]
[139] Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery. L W Seymour, R Duncan, P Kopečková, J Kopeček. Cancer Treat. Rev.. 14 (1987): 319-327. [doi]
[138] Poly[N-(2-Hydroxypropyl)methacrylamide] Macromolecules as Drug Carrier Systems. V Šubr, J Kopeček, R Duncan. Polymers in Controlled Drug Delivery. Eds. L Illum, S S Davis. (1987): 152-170.
[137] Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. R Duncan, P Kopeckova-Rejmanova, J Strohalm, I C Hume, H C Cable, J Pohl, J B Lloyd, J Kopeček. Br. J. Cancer. 55 (1987): 165-174. [doi]
[136] Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers: 3. Targeting by incorporation of galactosamine residues. Effect of route of administration. S A Cartlidge, R Duncan, J B Lloyd, P Kopeckova-Rejmanova, J Kopeček. J Control Release. 4 (1987): 265-278. [doi]
[135] Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers: 2. Effect of molecular weight on blood clearance and body distribution in the rat after intravenous administration. Distribution of unfractionated copolymer after intraperitoneal, subcutaneous or oral administration. S A Cartlidge, R Duncan, J B Lloyd, P Kopeckova-Rejmanova, J Kopeček. J Control Release. 4 (1987): 253-264. [doi]
[134] Separation of human lymphoid cells by affinity chromatography and cell surface labelling by hydroxyethyl methacrylate particles using monoclonal antibodies. H Tlaskalová Hogenová, J Coupek, A Frydrychova, V Vĕtvicka, J Kopeček, M Pospíšil, H Fiebig, L Prokesova, P Mancal. J. Chromatogr.. 376 (1986): 401-408. [doi]
[133] Pinocytic capture and exocytosis of rat immunoglobulin IgG-N-(2-hydroxy-propyl)methacrylamide copolymer conjugates by rat visceral yolk sacs culturedin vitro. R Duncan, H C Cable, J Strohalm, J Kopeček. Biosci. Rep.. 6 (1986): 869-877.
[132] Effect of a synthetic poly N-(2-hydroxypropyl)methacrylamide (Duxon) on haemopoiesis and graft-versus-host reaction. E Paluska, A Hruba, O Sterba, J Kopeček. Folia Biol. (Praha). 32 (1986): 91-102.
[131] Degradation of Oligopeptide Sequences Connecting Poly[N-(2- hydroxypropyl)methacrylamide] Chains by Lysosomal Cysteine Proteinases. V Šubr, J Kopeček, R Duncan. J Bioact Compat Polym. 1 (1986): 133-146. [doi]
[130] The Activity of Complement in the Presence of N-(2-hydroxypropyl)methacrylamide Copolymers. J Šimečková, B R̆íhová, D Plocová, J Kopeček. J Bioact Compat Polym. 1 (1986): 20-31. [doi]
[129] Synthetic polymers as carriers for chemotherapeutic agents. J B Lloyd, R Duncan, J Kopeček. Biochem. Soc. Trans.. 14 (1986): 391-392.
[128] Co-expression of different types of Fc receptors on murine peritoneal macrophages. Václav Větvička, Lubor Forn\textbackslashr u, Paul W Kincade, J Kopeček. Eur. J. Immunol.. 16 (1986): 901-905. [doi]
[127] Interaction of a Cationic N-(2-hydroxypropyl)methacrylamide Copolymer with Rat Visceral Yolk Sacs Cultured in vitro and Rat Liver in vivo. L A Mccormick, L C W Seymour, R Duncan, J Kopeček. J Bioact Compat Polym. 1 (1986): 4-19. [doi]
[126] Bioaffinity therapy with antibodies and drugs bound to soluble synthetic polymers. B Rihova, J Kopeček, P Kopeckova-Rejmanova, J Strohalm, D Plocová, H Semoradova. J. Chromatogr.. 376 (1986): 221-233. [doi]
[125] Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. R Duncan, L C W Seymour, L Scarlett, J B Lloyd, P Rejmanová, J Kopeček. Biochim. Biophys. Acta. 880 (1986): 62-71. [doi]
[124] A lysosomotropic polymeric inhibitor of cysteine proteinases. V Šubr, R Duncan, K Hanada, H C Cable, J Kopeček. J Control Release. 4 (1986): 63-68. [doi]
[123] Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers: Pinocytosis by rat visceral yolk sacs and rat intestine cultured in vitro. Effect of molecular weight on uptake and intracellular degradation. S A Cartlidge, R Duncan, J B Lloyd, P Rejmanová, J Kopeček. J Control Release. 3 (1986): 55-66. [doi]
[122] Poly(ethylene glycol)s containing enzymatically degradable bonds. K Ulbrich, J Strohalm, J Kopeček. Die Makromolekulare Chemie. 187 (1986): 1131-1144. [doi]
[121] In vivo and in vitro immunogenicity of water-soluble haptenated copolymers for mouse and human lymphocytes. H Tlaskalová Hogenová, J Kopeček, K Ulbrich, F Rypáček, M Pospíšil. Die Makromolekulare Chemie. 9S (1985): 137-143. [doi]
[120] Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugates. B R̆íhová, J Kopeček. J Control Release. 2 (1985): 289-310. [doi]
[119] Immunogenicity of N-(2-hydroxypropyl) methacrylamide copolymers. B R̆íhová, J Kopeček, K Ulbrich, V Chytrý. Die Makromolekulare Chemie. 9S (1985): 13-24. [doi]
[118] Polymers with Controlled Biodegradability as Carriers of Biologically Active Compounds (in Russian). J Kopeček. Zhur. Khim. Obsh.. 30 (1985): 372-378.
[117] Hydrophilic polymeric microspheres : Their use in immunological methods. L Fornusek, V Vĕtvicka, J Zídková, J Kopeček. Die Makromolekulare Chemie. 9S (1985): 125-127. [doi]
[116] Controlled Release of Drug Model from N-(2-Hydroxypropyl)methacrylamide Copolymers. J Kopeček, P Rejmanová, R Duncan, J B Lloyd. Ann NY Acad Sci. 446 (1985): 93-104.
[115] Targeting and Lysosomal Handling of Polymethacrylamide - Oligopeptide Conjugates. J B Lloyd, R Duncan, J Kopeček, P Rejmanová. Receptor-Mediated Targeting of Drugs. Eds. G Gregoriadis, G Poste, J Senior, A Trouet. (1985): 417-425.
[114] Methods of targeting N-(2-hydroxypropyl) methacrylamide copolymers to particular cell types. R Duncan, J B Lloyd, P Rejmanová, J Kopeček. Die Makromolekulare Chemie. 9 (1985): 3-12. [doi]
[113] Preparation of polymer-modified enzymes of prolonged circulation times. Poly[N-(2-hydroxypropyl) methacrylamide]-bound acetylcholinesterase. A Lääne, Aavo Aaviksaar, M Haga, V Chytrý, J Kopeček. Die Makromolekulare Chemie. 9 (1985): 35-42. [doi]
[112] Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers. P Rejmanová, J Kopeček, R Duncan, J B Lloyd. Biomaterials. 6 (1985): 45-48. [doi]
[111] Influence of medium and matrix composition on diffusivities in charged membranes. D Kirstein, H Braselmann, J Vacík, J Kopeček. Biotechnol. Bioeng.. 27 (1985): 1382-1384. [doi]
[110] Properties of macrophages from low- and high-responder strains of mice. I. Effect of antigenic stimulation. V Vĕtvicka, L Fornusek, B R̆íhová, J Kopeček. Folia Biol. (Praha). 31 (1985): 20-33.
[109] Macrophages of athymic nude mice: Fc receptors, C receptors, phagocytic and pinocytic activities.. V Vĕtvicka, L Fornusek, M Holub, J Zídková, J Kopeček. Eur J Cell Biol. 35 (1984): 35-40.
[108] Targeting of soluble cross-linked N-(2-hydroxypropyl)methacrylamide copolymers in vivo. A potential drug delivery system. S A Cartlidge, P Rejmanová, R Duncan, J Kopeček, J B Lloyd. Biochem. Soc. Trans.. 12 (1984): 1064-1065.
[107] Tyrosinamide residues enhance pinocytic capture of N-(2-hydroxypropyl)methacrylamide copolymers. R Duncan, H C Cable, P Rejmanová, J Kopeček, J B Lloyd. Biochim. Biophys. Acta. 799 (1984): 1-8.
[106] Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice. B R̆íhová, J Kopeček, K Ulbrich, M Pospíšil, P Mancal. Biomaterials. 5 (1984): 143-148.
[105] Polymers containing enzymatically degradable bonds, 9. Chymotrypsm catalyzed hydrolysis of a p-nitroanilide drug model, p bound via oligopeptides onto poly(vinylpyrrolidone-co-maleic anhydride). J Pató, M Azori, K Ulbrich, J Kopeček. Die Makromolekulare Chemie. 185 (1984): 231-237. [doi]
[104] Synthetic polymers as targetable carries for drugs. J B Lloyd, R Duncan, J Kopeček. Pure Appl. Chem.. 56 (1984): 1301-1304. [doi]
[103] Drug targeting to lysosomes. R Duncan, J Kopeček, J B Lloyd. Biochem. Soc. Trans.. 12 (1984): 1064-1065.
[102] Controlled biodegradability of polymers–a key to drug delivery systems. J Kopeček. Biomaterials. 5 (1984): 19-25.
[101] Synthesis of Tailor-Made Soluble Polymeric Drug Carriers. J Kopeček. Recent Advances in Drug Delivery Systems. Ed. S-W Kim. (1984): 41-62.
[100] Soluble synthetic polymers as potential drug carriers. R Duncan, J Kopeček. Adv. Polym. Sci.. 57 (1984): 51-101. [doi]
[99] An advantageous method for detection of Fc-receptors and for studying Fc-receptor-mediated phagocytosis. L Fornusek, J Kopeček, V Vĕtvicka. Immunol Lett.. 7 (1983): 29-33.
[98] Phagocytosis of 2-hydroxyethylmethacrylate copolymer particles by different types of macrophages. V Vĕtvicka, L Fornusek, J Kopeček, D Prikrylova. Folia Biol. (Praha). 29 (1983): 424-428.
[97] Polymers containing enzymatically degradable bonds, 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B. P Rejmanová, J Kopeček, J Pohl, M Baudyš, V Kostka. Die Makromolekulare Chemie. 184 (1983): 2009-2020. [doi]
[96] Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. R Duncan, J Kopeček, P Rejmanová, J B Lloyd. Biochim. Biophys. Acta. 755 (1983): 518-521.
[95] Development of N-(2-Hydroxypropyl)methacrylamide Copolymers as Carriers of Therapeutic Agents. R Duncan, J Kopeček, J B Lloyd. Polymers in Medicine Biomedical and Pharmacological Applications. Eds. E Chiellini, P Giusti. (1983): 97-113.
[94] Biodegradation of biomedical polymers. J Kopeček, K Ulbrich. Prog Polym Sci. 9 (1983): 1-58. [doi]
[93] Enzymatically Degradable Bonds in Synthetic Polymers. J Kopeček, P Rejmanová. Controlled Drug Delivery. Ed. S D Bruck. (1983): 81-124.
[92] Activation of poly[N-(2-hydroxypropyl)methacrylamide] for the binding of bioactive molecules, 2. Activation with cyanogen bromide. V Chytrý, J Kopeček. Die Makromolekulare Chemie. 184 (1983): 1345-1353. [doi]
[91] Activation of poly[N-(2-hydroxypropyl)methacrylamide] for the binding of bioactive molecules, 1. Activation with 4-nitrophenyl chloroformate. A Lääne, M Haga, Aavo Aaviksaar, V Chytrý, J Kopeček. Die Makromolekulare Chemie. 184 (1983): 1339-1344. [doi]
[90] Immunogenicity of N-(2-hydroxypropyl)-methacrylamide copolymers–potential hapten or drug carriers. B R̆íhová, K Ulbrich, J Kopeček, P Mancal. Folia Microbiol. (Praha). 28 (1983): 217-227.
[89] Polymers containing enzymatically degradable bonds, 7. Design of oligopeptide side-chains in poly[N-(2-hydroxypropyl)methacrylamide] copolymers to promote efficient degradation by lysosomal enzymes. R Duncan, H C Cable, J B Lloyd, P Rejmanová, J Kopeček. Die Makromolekulare Chemie. 184 (1983): 1997-2008. [doi]
[88] Synthesis of N-(2-hydroxypropyl)methacrylamide copolymers with antimicrobial activity. M V Solovskij, K Ulbrich, J Kopeček. Biomaterials. 4 (1983): 44-48.
[87] Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases. R Duncan, H C Cable, J B Lloyd, P Rejmanová, J Kopeček. Biosci. Rep.. 2 (1982): 1041-1046.
[86] Phagocytosis of human blood leukocytes: a simple micromethod. V Vĕtvicka, L Fornusek, J Kopeček, J Kaminkova, L Kasparek, M Vranova. Immunol Lett.. 5 (1982): 97-100.
[85] Polymers containing enzymatically degradable bonds. VI. Hydrophilic gels cleavable by chymotrypsin. K Ulbrich, J Strohalm, J Kopeček. Biomaterials. 3 (1982): 150-154.
[84] A convenient model system for the study of the influence of water-soluble polymer carrier on the interaction between proteins. V Chytrý, J Kopeček, P Sikk, R Sinijärv, Aavo Aaviksaar. Makromol. Chem. Rapid Commun.. 3 (1982): 11-15. [doi]
[83] Biodegradation of Polymers for Biomedical Use. J Kopeček. IUPAC Macromolecules. Eds. H Benoit, P Rempp. (1982): 305-320.
[82] Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl)methacrylamide copolymers. A potential drug delivery system. R Duncan, P Rejmanová, J Kopeček, J B Lloyd. Biochim. Biophys. Acta. 678 (1981): 143-150.
[81] Differences in phagocytic activity of methacrylate copolymer particles in normal and stimulated macrophages. L Fornusek, V Vĕtvicka, J Kopeček. Experientia. 37 (1981): 418-420.
[80] The photoelastic behaviour of dry and swollen networks of poly (N,N-diethylacrylamide) and of its copolymer with N-tert.butylacrylamide. J Hrouz, M Ilavský, K Ulbrich, J Kopeček. Eur Polym J. 17 (1981): 361-366. [doi]
[79] Polymers containing enzymatically degradable bonds, 4. Preliminary experiments in vivo. J Kopeček, I Cífková, P Rejmanová, J Strohalm, B Obereigner, K Ulbrich. Die Makromolekulare Chemie. 182 (1981): 2941-2949. [doi]
[78] Polymers containing enzymatically degradable bonds, 3. Poly[N-(2-hydroxypropyl)methacrylamide] chains connected by oligopeptide sequences cleavable by trypsin. K Ulbrich, J Strohalm, J Kopeček. Die Makromolekulare Chemie. 182 (1981): 1917-1928. [doi]
[77] Polymers containing enzymatically degradable bonds, 2. Poly[N-(2-hydroxypropyl)methacrylamide] chains connected by oligopeptide sequences cleavable by chymotrypsin. P Rejmanová, B Obereigner, J Kopeček. Die Makromolekulare Chemie. 182 (1981): 1899-1915. [doi]
[76] Polymers containing enzymatically degradable bonds, 1. Chymotrypsin catalyzed hydrolysis of p-nitroanilides of phenylalanine and tyrosine attached to side-chains of copolymers of N-(2-hydroxypropyl)methacrylamide. J Kopeček, P Rejmanová, V Chytrý. Die Makromolekulare Chemie. 182 (1981): 799-809. [doi]
[75] Hydrophilic Biomedical Polymers (in Bulgarian). J Kopeček. Chimija i Industrija. (1981): 224-227.
[74] Soluble Polymers in Medicine. J Kopeček. Systemic Aspects of Biocompatibility. Ed. D F Williams. (1981): 159-180.
[73] Covalent attachment of chymotrypsin to poly[N-(2-hydroxypropyl)methacrylamide]. A Lääne, V Chytrý, M Haga, P Sikk, Aavo Aaviksaar, J Kopeček. CCCC. 46 (1981): 1466-1473. [doi]
[72] New types of synthetic infusion solutions. The effect of Duxon on cell proliferation in vitro. J Cinatl, O Sterba, E Paluska, V Polednova, J Kopeček. Ceskoslovenska farmacie. 29 (1980): 134-138.
[71] Duxon–a new Czechoslovak–made infusion solution–an experimental contribution to biological evaluation. O Sterba, Z Uhlirova, R Petz, L Viktora, A Jirasek, J Kopeček. Cas. Lek. Cesk.. 119 (1980): 994-997.
[70] Degradation of side chains of N-(2-hydroxypropyl) methacrylamide copolymers by lysosomal enzymes. R Duncan, J B Lloyd, J Kopeček. Biochem Biophys Res Commun. 94 (1980): 284-290.
[69] Polymers containing enzymatically degradable bonds V. Hydrophilic polymers degradable by papain. K Ulbrich, E I Zacharieva, B Obereigner, J Kopeček. Biomaterials. 1 (1980): 199-204.
[68] Immunosuppressive effects of a synthetic polymer poly N-(2-hydroxypropyl)methacrylamide (Duxon). E Paluska, J Cinatl, L Korcakova, O Sterba, J Kopeček, A Hruba, J Nezvalova, R Stanek. Folia Biol. (Praha). 26 (1980): 304-311.
[67] Strong-acid membranes with enhanced hydrophilicity. V K\textbackslashr udela, J Vacík, J Kopeček. J Memb Sci. 6 (1980): 123-131. [doi]
[66] Regulation of transport in artificial membranes by environmental hydrogen-ion concentration. H Braselmann, J Vacík, J Kopeček, D Kirstein. Eur Polym J. 16 (1980): 431-435. [doi]
[65] Comparison of the functional activity of normal and stimulated peritoneal exudate cells in suspension and after adherence to the substrate. V Vĕtvicka, V Viklicky, L Jaroskova, J Kopeček. Folia Biol. (Praha). 25 (1979): 403-404.
[64] Porous copolymers of methacrylic acid with N-(2-hydroxypropyl) methacrylamide and (2-hydroxyethyl) methacrylate. Study of sorption properties. J Vacík, L K Shataeva, G V Samsonov, Jaroslav Kálal, J Kopeček. CCCC. 44 (1979): 1931-1941. [doi]
[63] Porous copolymers of methacrylic acid with N-(2-hydroxypropyl) methacrylamide and (2-hydroxyethyl) methacrylate. Preparation, swelling and morphology. J Vacík, Z Pelzbauer, Nadezhda N Kuznetsova, K P Papukova, L K Shataeva, G V Samsonov, Jaroslav Kálal, J Kopeček. CCCC. 44 (1979): 1925-1930. [doi]
[62] Permeability of heterogeneous membranes based on methacrylic acid. L K Shatayeva, G V Samsonov, J Vacík, J Kopeček, J Kalal. J Appl Polym Sci. 23 (1979): 2245-2251. [doi]
[61] Reactive copolymers of N-(2-hydroxypropyl) methacrylamide with N-methacryloylated derivatives of l-leucine and l-phenylalanine. II. Reaction with the polymeric amine and stability of cross-links towards chymotrypsin in vitro. J Kopeček, P Rejmanová. J. Polym. Sci., Polym. Symp.. 66 (1979): 15-32. [doi]
[60] Cross-linked copolymers of N,N-diethylacrylamide with improved mechanical properties. K Ulbrich, J Kopeček. J. Polym. Sci., Polym. Symp.. 66 (1979): 209-219. [doi]
[59] Preparation of polymerizable derivatives of N-(4-aminobenzenesulfonyl)-n´-butylurea. B Obereigner, M Burešová, A Vrána, J Kopeček. J. Polym. Sci., Polym. Symp.. 66 (1979): 41-52. [doi]
[58] Deformational, swelling, and potentiometric behavior of ionized gels of 2-hydroxyethyl methacrylate–methacrylic acid copolymers. M Ilavský, K Dušek, J Vacík, J Kopeček. J Appl Polym Sci. 23 (1979): 2073-2082. [doi]
[57] Supermolecular Structure of Hydrophilic Polymers Based on Poly(Glycol Methacrylates) Contacted with the Organism's Tissue (in Russian). J Kalal, L Šprincl, J Kopeček, T E Lipatova, E V Lebedev, N I Dovgopol. Vysokomol. Soed.. 20 (1978): 751-755.
[56] Permeability of hydrophilic membranes based on N-substituted (meth)acrylamides. J Vacík, K Ulbrich, J Exner, J Kopeček. CCCC. 43 (1978): 1221-1226. [doi]
[55] Poly[N-(2-hydroxypropyl)methacrylamide]. IV. Heterogeneous polymerization. J Strohalm, J Kopeček. Die Angewandte Makromolekulare Chemie. 70 (1978): 109-118. [doi]
[54] Synthetic Polymers in Chemotherapy: General Problems. J Kalal, J Drobník, J Kopeček, J Exner. Polymeric Drugs. Eds. L G Donaruma, O Vogl. Academic Press (1978): 131-159.
[53] Water Soluble Polymers for Medicine. Jaroslav Kálal, J Drobník, J Kopeček, J Exner. British Polymer Journal. 10 (1978): 111-114. [doi]
[52] Preparation and properties of poly-(N-butylmethacrylamide) networks. K Ulbrich, K Dušek, M Ilavský, J Kopeček. Eur Polym J. 14 (1978): 45-49. [doi]
[51] Synthesis and activity of a polymer which contains insulin covalently bound on a copolymer of N-(2-hydroxypropyl)methacrylamide and N-methacryloyldiglycyl p-nitrophenyl ester. V Chytrý, A Vrána, J Kopeček. Die Makromolekulare Chemie. 179 (1978): 329-336. [doi]
[50] Preparation and properties of poly(2,4-pentadiene-1-ol). K Ulbrich, M Ilavský, B Obereigner, J Kopeček. Die Angewandte Makromolekulare Chemie. 67 (1978): 137-149. [doi]
[49] pH-dependent electrochemical behaviour of hydrophilic ampholytic membranes. V K\textbackslashr udela, J Vacík, J Kopeček. Eur Polym J. 13 (1977): 811-813. [doi]
[48] Biological Effects of 2,4-Pentadiene-1-ol. O Benesova, L Šprincl, K Ulbrich, B Obereigner, J Drobník, J Kalal, J Kopeček. Chem. Biol. Interact.. 18 (1977): 111-118. [doi]
[47] Reactive copolymers of N-(2-hydroxypropyl)methacrylamide with N-methacryloylated derivatives of L-leucine and L-phenylalanine, 1. Preparation, characterization, and reactions with diamines. J Kopeček. Die Makromolekulare Chemie. 178 (1977): 2169-2183. [doi]
[46] Permeability of metabolites through hydrophilic membranes. J Vacík, M Czaková, J Exner, J Kalal, J Kopeček. CCCC. 42 (1977): 2786-2790. [doi]
[45] Polymerization kinetics of N,N-diethylacrylamide. K Ulbrich, L Čech, J Kalal, J Kopeček. CCCC. 42 (1977): 2666-2671. [doi]
[44] Preparation and properties of poly(N-ethylmethacrylamide) networks. K Ulbrich, M Ilavský, K Dušek, J Kopeček. Eur Polym J. 13 (1977): 579-585. [doi]
[43] Soluble biomedical polymers. J Kopeček. Polim Med. 7 (1977): 191-221.
[42] Aminolyses of monomeric and polymeric 4-nitrophenyl esters of N-methacryloylamino acids. P Rejmanová, J Labský, J Kopeček. Die Makromolekulare Chemie. 178 (1977): 2159-2168. [doi]
[41] New types of synthetic infusion solutions. III. Elimination and retention of poly-[N-(2-hydroxypropyl)methacrylamide] in a test organism. L Šprincl, J Exner, O Sterba, J Kopeček. J. Biomed. Mater. Res.. 10 (1976): 953-963. [doi]
[40] A simple test for immunogenicity of colloidal infusion solutions- the draining lymph node activation.. L Korcakova, E Paluska, V Haskova, J Kopeček. Z Immunitatsforsch Exp Klin Immunol. 151 (1976): 219-223.
[39] Mucopolysaccharide complexes in the fibrous tissue surrounding hydrophilic polymers in subcutaneous implantation. L Šprincl, T L Terescenko, J Kalal, T E Lipatova, J Kopeček, G A Pchakadze. Polim Med. 6 (1976): 185-190.
[38] Comparative Characteristics of Polyurethanes and Hydrophilic Polymers Based on Poly(Glycol Methacrylates) Used as Alloplastics (in Ukrainian). T E Lipatova, G A Pchakadze, T L Terescenko, J Kalal, L Šprincl, J Kopeček. Izv. Ukr. Acad. Sci.. 3 (1976): 33-45.
[37] Enzymatic cleavage of side chains of synthetic water-soluble polymers. J Drobník, J Kopeček, J Labský, P Rejmanová, J Exner, V Saudek, J Kalal. Die Makromolekulare Chemie. 177 (1976): 2833-2848. [doi]
[36] Polymerization kinetics of N-ethylacrylamide. K Ulbrich, J Kopeček. CCCC. 41 (1976): 61-66. [doi]
[35] Radical polymerization of n-substituted methacrylamides. K Ulbrich, J Kopeček. Eur Polym J. 12 (1976): 183-187. [doi]
[34] New Types of Polyurethane Tissue Adhesives and Their Application in Surgery (In Czech). T E Lipatova, G A Pchakadze, T L Terescenko, L Šprincl, J Kalal, J Kopeček. Voj. zdrav. listy. 45 (1976): 25-29.
[33] Copolymerization of N-ethylacrylamide with N-monosubstituted methacrylamides. J Strohalm, K Ulbrich, J Exner, J Kopeček. Die Angewandte Makromolekulare Chemie. 49 (1976): 83-92. [doi]
[32] Mechanical Responses of 2-Hydroxyethyl Methacrylate-Methacrylonitrile and 2-Hydroxyethyl Methacrylate-Acrylonitrile Copolymer Networks. J Janáĉek, J Kolarik, J Vacík, J Kopeček. Int J Polym Mater. 5 (1976): 59-70. [doi]
[31] Relaxation Behavior of Poly(N-monosubstituted Methacrylamides). J Kolarik, J Kopeček, J Vacík, J Janáĉek. Int J Polym Mater. 5 (1976): 89-97. [doi]
[30] New types of synthetic infusion solutions. Basic biological properties of poly(N-(2-hydroxypropyl) methacrylamide). O Sterba, E Paluska, O Jozova, J Spunda, J Nezvalova, L Šprincl, J Kopeček, J Cinatl. Cas. Lek. Cesk.. 114 (1975): 1268-1270.
[29] Specific resistances of hydrophilic membranes containing ionogenic groups. J Vacík, J Kopeček. J Appl Polym Sci. 19 (1975): 3029-3044. [doi]
[28] Adjusting of Thin Layer Resistors with an Anodizing Electrode (in Czech). S Luby, E Sumbalova, J Kopeček. Elektrotechnicky casopis. 26 (1975): 297-304.
[27] Concentration potentials of hydrophilic membranes containing ionogenic groups. J Vacík, V K\textbackslashr udela, J Kopeček. Eur Polym J. 11 (1975): 331-335. [doi]
[26] Long-term experience with poly(glycol monomethacrylate) gel in plastic operations of the nose. Z Voldrich, Z Tomanek, J Vacík, J Kopeček. J. Biomed. Mater. Res.. 9 (1975): 675-685. [doi]
[25] Relaxation Behaviour of Poly(2-Hydroxyethyl Acrylate) and of Its Copolymers with 2-Hydroxyethyl Methacrylate. J Kolarik, J Vacík, J Kopeček. Int J Polym Mater. 3 (1975): 259-267. [doi]
[24] Evaluation of Biological Properties of Polymeric Materials (in Czech). L Šprincl, J Kalal, J Kopeček. Lekar a technika. 6 (1974): 110-114.
[23] Poly[N-(2-hydroxypropyl)methacrylamide]—iii Crosslinking copolymerization. J Kopeček, H Baẑilová. Eur Polym J. 10 (1974): 465-470. [doi]
[22] Poly[N-(2-hydroxypropyl)methacrylamide]—ii Hydrodynamic properties of dilute solutions. M Bohdanecky, H Baẑilová, J Kopeček. Eur Polym J. 10 (1974): 405-410. [doi]
[21] Relationship between the structure and biocompatibility of hydrophilic gels. J Kopeček, L Šprincl. Polim Med. 4 (1974): 109-117.
[20] Biocompatibility of poly (2,4-pentadiene-1-ol). K Ulbrich, L Šprincl, J Kopeček. J. Biomed. Mater. Res.. 8 (1974): 155-161. [doi]
[19] Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization. J Kopeček, H Baẑilová. Eur Polym J. 9 (1973): 7-14. [doi]
[18] Effect of the structure of poly(glycol monomethacrylate) gel on the calcification of implants. L Sprinel, J Kopeček, D Lím. Calcif Tissue Res. 13 (1973): 63-72.
[17] New types of synthetic infusion solutions. I. Investigation of the effect of solutions of some hydrophilic polymers on blood. J Kopeček, L Šprincl, D Lím. J. Biomed. Mater. Res.. 7 (1973): 179-191. [doi]
[16] Effect of the hydrophilic character of the polymeric backbone on membrane permeability. J Kopeček, J Vacík. CCCC. 38 (1973): 854-860. [doi]
[15] Biological tolerance of poly(N-substituted acrylamides). J Kopeček, L Šprincl, H Baẑilová, J Vacík. J. Biomed. Mater. Res.. 7 (1973): 111-121. [doi]
[14] Biological tolerance of ionogenic hydrophilic gels. L Šprincl, J Vacík, J Kopeček. J. Biomed. Mater. Res.. 7 (1973): 123-136. [doi]
[13] Mechanism of three-dimensional polymerization of glycol methacrylates. IV. The system triglycol monomethacrylate-glycol dimethacrylates-water. J Kopeček, D Lím. CCCC. 36 (1971): 3394-3398. [doi]
[12] Mechanism of three-dimensional polymerization of glycol methacrylates. III. Contribution to the polymerization kinetics of the system diglycol monomethacrylate-glycol dimethacrylates-water. J Kopeček, D Lím. CCCC. 36 (1971): 2703-2707. [doi]
[11] Effect of porosity of heterogeneous poly(glycol monomethacrylate) gels on the healing-in of test implants. L Šprincl, J Kopeček, D Lím. J. Biomed. Mater. Res.. 5 (1971): 447-458. [doi]
[10] Permeability of membranes containing ionogenic groups. J Kopeček, J Vacík, D Lím. J Polym Sci A1. 9 (1971): 2801-2815. [doi]
[9] Mechanism of the three-dimensional polymerization of glycol methacrylates. II. The system glycol monomethacrylate–glycol dimethacrylates–solvents. J Kopeček, D Lím. J Polym Sci A1. 9 (1971): 147-154. [doi]
[8] Biological tolerance of poly(N-substituted methacrylamides). L Šprincl, J Kopeček, J Vacík, D Lím. J. Biomed. Mater. Res.. 5 (1971): 197-205. [doi]
[7] Performance of Porous Cellulose Acetate Membranes for the Reverse Osmosis Separation of Mixtures of Organic Liquids. J Kopeček, S Sourirajan. Ind. Eng. Chem. Proc. Des. Dev.. 9 (1970): 5-12. [doi]
[6] Reverse Osmosis. J Kopeček. Chem. Listy.. 63 (1969): 1338-1353.
[5] Equisorptic compositions in reverse osmosis. J Kopeček, S Sourirajan. Can J Chem. 47 (1969): 3467-3469.
[4] Performance of Porous Cellulose Acetate Membranes in Some Reverse Osmosis Experiments. J Kopeček, S Sourirajan. Ind. Eng. Chem. Prod. Res. Dev.. 8 (1969): 274-279. [doi]
[3] Structure of porous cellulose acetate membranes and a method for improving their performance in reverse osmosis. J Kopeček, S Sourirajan. J Appl Polym Sci. 13 (1969): 637-657. [doi]
[2] Mechanism of three-dimensional polymerization of the system methyl methacrylate–glycol dimethacrylate. I. Determination of the structure of the three-dimensional product. J Jokl, J Kopeček, D Lím. J Polym Sci A1. 6 (1968): 3041-3048. [doi]
[1] Mechanism of Three-Dimensional Polymerization of Glycol Methacrylates. J Kopeček, J Jokl, D Lím. J Polym Sci C. 16 (1968): 3877-3889. [doi]